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CD34, a pan-selectin binding protein when glycosylated, has been shown to be involved in 
leukocyte migration to the site of inflammation. However, only one report is available on the 
expression and role of CD34 in neutrophil recruitment during acute lung inflammation. Hence, we 
proceeded to study the expression of CD34 in lung tissue and its role in migration of neutrophils 
into the lungs using a mouse model of endotoxin induced acute lung inflammation.  
Acute lung inflammation was induced via intranasal E. coli O55:B5 LPS (50 μg) instillation in 
CD34 KO and WT C57BL/6 mice. Mice (male and female) from each phenotype (i.e. WT and 
CD34 KO) were divided into five sub-groups comprising of 0, 3, 9, 15 and 24-hour LPS treatment 
time-points. Each time-point had five-seven WT mice and five-seven CD34 KO mice.  
Experiments were carried out to look at several factors associated with an inflammatory response 
in the lungs of mice, including peripheral blood cell counts, total and differential leukocyte cell 
counts in BALF, adherent neutrophils left in the lung after lavage (MPO levels, Gr-1 IF staining), 
lung vascular permeability (BAL total protein), lung inflammation scoring (H&E staining), and 
cytokine and chemokine levels in BALF. 
Our results demonstrate that intranasal LPS challenge induces time-dependent inflammatory 
responses in WT mice (N = 5-7/time-point) and CD34 KO mice (N = 5-7/time-point). While there 
was no difference in the total or differential leukocyte counts, lung MPO content in CD34 KO was 
lower than WT group at 3 h time-point (p=0.0308). The MPO levels in CD34 KO mice begin to 
rise at 9 h (p=0.0021), as opposed to an early 3 h rise in WT mice (p=0.0001), indicating that CD34 
KO mice display delays in lung neutrophil recruitment kinetics. CD34 KO mice do not display loss 
of lung vascular barrier properties as suggested by lower total protein in BAL supernatant in CD34 
KO mice at 3 h (p=0.0452) and 24 h (p=0.0113) time-points. In addition, immunofluorescence 
lung staining shows distinct alveolar staining with Gr-1, a marker for polymorphonuclear 
leukocytes and a subset of inflammatory monocytes/macrophages. Lung immunofluorescent 
staining in WT mice at baseline (0 h No LPS) reveals CD34 expression in the bronchiolar 
epithelium, in addition to alveolar septa.  
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Several pro-inflammatory cytokines and chemokines (TNF-α, IL-1β, KC, MIP-1α, IL-6, IL-10 and 
IL-12 p40 sub-unit; p<0.05) had higher levels in WT compared to CD34 KO group, at 3 h. These 
results indicate that CD34 KO mice potentially lack in neutrophil activation responses like TLR4 
mediated IL-1β inflammasome activation when compared to WT mice since LPS induces innate 
immune (TLR4) mediated NF-κB activation, IL-1β inflammasome activation as well as cell-death 
induced cytokine/chemokine responses. 
Thus, given that CD34 has pan-selectin affinity, the high CD34 expression in the bronchiolar 
epithelium as well as alveolar septa, point towards a possible role of CD34 in lung neutrophil 
adherence and activation but not vascular permeability kinetics, as indicated by higher lung MPO, 
histological lung inflammatory changes as well as lung innate cytokine and chemokine secretion, 
and higher BAL total protein content in LPS exposed WT mice when compared to CD34 KO.  





I would first like to thank my supervisor, Dr. Baljit Singh, for giving me the opportunity to join his 
lab. He has been extremely supportive and has provided valuable guidance throughout my program. 
I would also like to thank Dr. Singh for encouraging me to participate in the NSERC-CREATE 
ITraP program, which was a great experience for me. I would not have been able to finish my 
studies without his guidance, support and patience, for which I am forever grateful.  
 
I would like to acknowledge my co-supervisor, Dr. Gurpreet Aulakh, for her immense support and 
guidance during my program. She has been pivotal in my project for providing her expertise during 
my experiments, data analysis as well as during the thesis writing process. Dr. Aulakh has been 
most supportive and patient throughout. She always made time for meetings and discussions 
regarding my project. I am very thankful for all her help and support.  
 
I would also like to acknowledge my committee members, Dr. John Gordon and Dr. Julia 
Montgomery for their guidance and patience, the committee chair, Dr. Daniel MacPhee, for his 
support in facilitating committee meetings. They all have provided their valuable perspective into 
my project.  
 
I would like to thank several people for their technical assistance during my experiments. I would 
like to thank the animal facility staff of the Laboratory Animal Services Unit and Animal Care 
Unit. Especially, Brandee Pastoor, Kerri Walker, Amila Nawarathne, and Michele Moroz for 
providing immense support in animal care and guiding me through their facilities for my 
experiments. I would like to acknowledge Eiko Kawamura for her assistance with confocal 
microscopy, and Larhonda Sobchishin for her assistance in immunoelectron microscopy. I would 
also like to thank Karen Yuen for her tissue processing assistance. I would also like to thank Cindy 
Pollard for her administrative support, Paula Nordick for assistance with handling finances for our 
lab, and Cheryl Hack for her support with shipping and receiving. I would also like to thank Jim 
Gibbons and Dr. Jaswant Singh, for teaching and guiding me during my time as a teaching assistant 
for veterinary microscopic anatomy course. I would also like to thank Monica Salles, Rhonda 
vi 
 
Shewfelt, Nicole Wood, Brent Bobick, for their guidance during my term as a teaching assistant 
for comparative anatomy of domestic animals. 
 
I am forever grateful to my family for their unconditional love and support throughout. I am 
thankful to my lab mates for their support and motivation. They have been most helpful during 
difficult times and have been very kind to provide guidance and assistance during my experiments. 
  vii 
 
TABLE OF CONTENTS 
 
PERMISSION TO USE……………….…………….………………………….……....………. i 
DISCLAIMER………………………………………………………………...…………...….... ii 
ABSTRACT…………………………………………………………………...…………...….... iii  
ACKNOWLEDGEMENTS……………………….……………………….….………….……...v 
TABLE OF CONTENTS……………….…………………………….……………….………. vii 
TABLE OF FIGURES…………….………………………………….……………….………...ix 
LIST OF ABBREVIATIONS………….…………………………….……………….……....... x 
CHAPTER 1: INTRODUCTION………………………….………………...……….……........1 
CHAPTER 2: LITERATURE REVIEW.....................................................................................4 
2.1 Acute Lung Injury……………………………………………………….………….…4 
2.2 Acute Inflammation………….….….…………………………….….………………..5 
2.3 Animal models of ALI/ARDS…………………………………………………………6 
2.4 Cell Migration during Inflammation………….…..………….……..........……………9  
2.4.1 Leukocyte migration to the site of inflammation…………….…………..….9 
2.4.1.1 Leukocyte Recruitment Cascade…………………………………..9 
2.4.1.2 Cytoskeletal Dynamics during Cell Migration…………………...10 
 2.4.2 Neutrophil recruitment into the lung…………………................................11 
2.5 CD34-family Proteins…...…………..……………………………….…………….…12 
2.5.1 Introduction……………………………………….…..….…………………12 
            2.5.2 CD34 expression………………………………………………………..…..12 
            2.5.3 Functions of CD34-family proteins……………….………..…..…………..13 
2.6 CD34 and Lung Inflammation…….……….………….….….…………………….…20 
2.7 Hypothesis and objective……………….…………….……………………...….....…21 
2.8 Rationale for experiments…………………………….………………………............21 
CHAPTER 3: MATERIALS AND METHODS…………………………………....................22 
3.1 Animals………….…………………………………………………….…………...…22 
3.2 Induction of lung injury ….….….…………………………….….…………………..22 
3.3 Broncho-alveolar lavage (BAL) analysis ……………………………………………25 
3.4 Myeloperoxidase assay ………………….………………………………………...…25 
viii 
 
3.5 Immunofluorescence staining (IF) ………………….…………………………….…25 
3.6 Broncho-alveolar lavage (BAL) total protein estimation assay……………………...26 
3.7 Histology ………………….…………………………………………………………27 
3.8 Cytokine analysis ………………….…………………………………………………27 
3.9 Statistical analyses ………………….……………………………………………..…27 
CHAPTER 4: RESULTS…………...………………………………………….……………….29 
4.1 Effect of CD34 on the peripheral blood counts…………………..…………………..29 
4.2 Inflammatory cell migration into the lungs of CD34 KO mice and WT mice upon LPS 
challenge ……………………….…………………………………………………..….…36 
4.3 CD34 KO mice show altered lung pathology upon LPS challenge compared     with 
the WT mice …………...…………………………………………….………..…………43 
4.4 CD34 knock-out mice show reduced expression of TNF-α, IL-1β, KC, IL-6, IL-10, 
and MIP-1α upon LPS challenge compared with the WT mice …..………..……………51 
CHAPTER 5: DISCUSSION………………………………………………………...………....64 








TABLE OF FIGURES 
Fig.3.1: Experimental set-up ....................................................................................................................... 24 
Fig.4.1: WBC Counts in blood samples ...................................................................................................... 31 
Fig.4.2: SEG Counts in blood samples ........................................................................................................ 32 
Fig.4.3.A-B: Eosinophil and Lymphocyte counts in blood samples ........................................................... 33 
Fig.4.4: Platelet counts in blood samples .................................................................................................... 35 
Fig.4.5: BAL leukocyte counts .................................................................................................................... 38 
Fig.4.6.A-B: Bronchoalveolar lavage (BAL) differential cell counts ......................................................... 39 
Fig.4.7: Myeloperoxidase estimation in mouse lungs ................................................................................. 41 
Fig.4.8: Immunofluorescence staining in mouse lung sections ................................................................... 42 
Fig.4.9: BAL total protein (μg) estimation assay ........................................................................................ 45 
Fig.4.10: Lung H&E histology (0, 3 h) ....................................................................................................... 46 
Fig.4.11: Lung H&E histology (0, 9, 15, 24 h) ........................................................................................... 47 
Fig.4.12: Histological scoring of inflammation in lung sections ................................................................ 49 
Fig.4.13.A-D: TNF-α, IL-1β, KC and IL-6 content in BAL fluid ............................................................... 53 
Fig.4.14.A-B: IL-10 and MIP-1α content in BAL fluid .............................................................................. 56 
Fig.4.15: IL-12(p40) content in BAL fluid ................................................................................................. 58 
Fig.4.16.A-B: IFN-γ and G-CSF content in BAL fluid ............................................................................... 59 
Fig.4.17.A-B: MIP-1b and MCP-1 content in BAL fluid ........................................................................... 61 
Fig.4.18: RANTES content in BAL fluid .................................................................................................... 63  
Fig.5.1 Role of CD34 in LPS-induced acute lung injury in mice……………………………………...…..69 
Fig.A.1.A-B: BAL Monocyte and Lymphocyte counts .............................................................................. 75 
Fig.B.1: Immunohistochemical staining in dog lung sections..................................................................... 79 
Fig.B.2: Western blot analysis in dog lung sections ................................................................................... 81 
Fig.B.3: Immunohistochemical staining in pig lung sections ..................................................................... 82 
Fig.B.4: CD34 immunofluorescence staining in WT mouse lung section .................................................. 83 
Fig.C.1.A-C: IL-13, IL-9 and IL-3 content in BAL fluid…………………………………………….....…84 
Fig.C.2.A-B: IL-4 and IL-2 content in BAL fluid ....................................................................................... 86  
Fig.C.3: IL-5 content in BAL fluid………………………………………………………………………...88 
Fig.C.4: IL-17 content in BAL fluid ........................................................................................................... 89 
Fig.C.5: IL-1a content in BAL fluid……………………………………………………………………….90 






LIST OF ABBREVIATIONS 
 
ALI    Acute lung injury 
ARDS    Acute respiratory distress syndrome 
BAL    Broncho-alveolar lavage 
BALF    Broncho-alveolar lavage fluid 
CD34 KO  CD34 knock-out 
IF    Immunofluorescence staining 
IHC   Immunohistochemistry 
LPS    Lipopolysaccharide 
MPO    Myeloperoxidase 
ROS   Reactive oxygen species 
vWF    von Willebrand Factor 
WBC    White blood cell 











CHAPTER 1: INTRODUCTION 
 
Inflammation is essential for tissue homeostasis and protection against external infections and 
injury. Acute Lung Injury (ALI) in humans is characterized by an increase in permeability of the 
alveolar-capillary barrier, edema, and infiltration of neutrophils in the lung. ALI is marked by 
increased mortality (40%) due to activated neutrophil alveolar infiltrates comprising of chemotactic 
peptides, cytokines like IL-1, IL-6, IL-8, and damaging mediators like reactive oxygen species 
(ROS), and granule proteins, which are responsible for tissue damage in the lungs (Haslett et al., 
1989; Haslett, 1999; Matute-Bello et al., 2003; Matute-Bello, 2008 ; Grommes et al., 2011). 
Therefore, it is important to find novel proteins that regulate neutrophil migration and activation. 
Lipopolysaccharide, which is found on the outer surface of most of the gram-negative bacteria, 
triggers immunological response by binding to the molecular receptors present on the surface of 
immune cells. In humans, this initiates a cascade of intracellular signals, leading to activation of 
nuclear transcription factors (Inagawa et al., 2011). TLR4 recognizes LPS (Alexander. C., 2001). 
Tissue-resident macrophages and mast cells are the mediators of this recognition of damage. 
Macrophages, epithelial cells and endothelial cells release cytokines, chemokines, and 
inflammatory mediators (Maas et al., 2018). They release pro-inflammatory cytokines, like tumor 
necrosis factor-alpha (TNF-α), IL-6, IL-12, Interferon gamma (IFN-γ), interleukin-1-beta (IL-1β) 
(Alexander. C., 2001; Ashley, 2012). TNF-α, which is released predominantly by macrophages 
and monocytes, plays a vital role in responding to host injury by starting an immune/cytokine 
cascade. Levels of pro-inflammatory cytokines IL-6 and CXCL8 (IL-8) increase following the 
release of TNF-α. CXCL8 (IL-8) is an essential chemotactic factor and plays a role in the 
development of ALI. However, mice do not have a gene for CXCL8, but they have KC and MIP-
2. KC and MIP-2 are considered functional homologs of human CXCL8 since they play an essential 
role in the neutrophil recruitment into the lungs. KC and MIP-2 share 89% amino acid sequence 
similarity and adaptor protein MyD88 regulates their TLR-dependent production, but MIP-2 has 
also been shown to be produced via an alternative pathway utilizing a different adaptor protein, 
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TRIF (De Filippo et al., 2008). Therefore, we included KC in the cytokine analysis for this project. 
IL-10, which is the critical anti-inflammatory cytokine, primarily acts on macrophages, 
neutrophils, mast cells, and eosinophils. IL-10 can inhibit transcription of genes encoding pro-
inflammatory cytokines like TNFα, IL-6, IL-8, IL-12, and IL-1. NF-κB activates the gene 
transcription for cytokines mentioned above. IL-10 levels increase after LPS challenge (Hackett et 
al., 2008).  
Neutrophils, at least in the peripheral circulation, migrate from venules in response to luminal 
chemotactic gradients initiated by an infection or injury. Neutrophil migration begins through the 
formation of (E/P-selectin) selectin-mediated nascent contacts with the endothelial PSGL-1, 
followed by firm adhesion induced by integrin-mediated contacts with VCAM-1/ICAM-1, 
intraluminal crawling, and finally, transmigration across specific sites termed as endothelial 
“domes” or transmigratory “cups” (Ley et al., 2007; Phillipson et al., 2008; Petri et al., 2011). 
Endothelial cell shape is maintained by cytoskeletal actin, vimentin, and cortical actin linkers like 
ERM (ezrin, radixin, and moesin) proteins (Niggli, 2003; Niggli et al., 2008). 
CD34-family proteins are proposed to play various roles depending on the site of expression 
(Nielsen, 2008). The cell surface protein CD34 is reported in multiple human tissues and cells 
including hematopoietic stem cells (Andrews, 1989), vascular endothelial cells and inactivated 
platelets (Lewandowska et al., 2003). Although, CD34 is expressed in vascular endothelium, it is 
glycosylated only in high endothelial venules in secondary lymphoid organs, to allow binding of 
L-selectin expressed on lymphocytes (Nielsen, 2008). In the absence of HEV-specific 
glycosylation elsewhere, negatively charged and large extracellular domains of CD34 may create 
repulsion and steric hindrance, which prevent interaction of integrin on endothelium with their 
ligands on lymphocytes, thereby blocking cell adhesion (Nielsen, 2008). CD34 inhibited cell 
adhesion and cell rounding and induced microvillus formation in HEK293T cells. CD34 expression 
was forced in HEK293T cells, which led to microvilli formation, rounding of cells, and 
phosphorylation of ezrin/radixin/moesin (ERM) proteins, while inhibiting integrin-mediated cell 
re-attachment to HEK293T cells (Delia et al., 1993; Ohnishi et al., 2013). CD34 does not interact 
with the NHERF ligands (PDZ-family proteins ezrin-radixin-moesin-binding phosphoprotein 50), 
unlike podocalyxin (Haslett, 1999; Tan et al., 2006). 
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In a mast cell and eosinophil-dependent asthma (Th2-dependent) model, eosinophils from CD34 -
/- mice show significantly less pulmonary migration compared with eosinophils from WT mice. 
CD34 KO and WT mice mount a comparable immune response. This suggests that CD34 plays an 
essential role in the cell trafficking by acting as an anti-adhesive or pro-adhesive molecule, 
depending on the cell and tissue type (Blanchet et al., 2007). 
Mucosal dendritic cells have been shown to express CD34. CD34 KO DCs were unable to migrate 
to lymph nodes to present antigen to T cells while preserving the innate inflammatory response 
(Blanchet, 2011). In this murine hypersensitivity pneumonitis (Th1/Th17-dependent disease) 
model, CD34 KO mice protected against the development of hypersensitivity pneumonitis. 
Given its expression on vascular endothelial cells and leukocytes, to my knowledge, not many 
reports are available on the role of CD34 in acute lung inflammation. One recent report in 
bleomycin-induced lung inflammation showed that absence of CD34 led to loss of structural 
integrity of the alveoli (Lo et al., 2017). Considering the role of CD34 in cell shape and attachment 
(Delia et al., 1993; Ohnishi et al., 2013), and its role in leukocyte recruitment in allergic (Blanchet 
et al., 2007) and hypersensitivity models (Blanchet, 2011), we hypothesized that CD34 KO mice 
will show lower vascular permeability, cytokine and chemokine release, and lower leukocyte 




CHAPTER 2: LITERATURE REVIEW 
 
2.1 Acute Lung injury: 
 
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), which is a severe form 
of ALI, have a mortality rate of 30-65% with a very high incidence rate (Williams, 2014). Per the 
American-European consensus conference definition, ALI is marked by acute onset, partial 
pressure of arterial oxygen to fraction of inspired oxygen ratios (PaO2/FIO2) of less than 300 mm 
Hg, bilateral alveolar infiltrates on chest radiograph and Pulmonary artery wedge pressure (PAWP) 
less than 18 mm Hg or no clinical evidence of left atrial hypertension. ALI can be caused by several 
factors including bacterial infections, sepsis, aspiration of gastric contents, toxic inhalation, near 
drowning, acute pancreatitis, hemorrhagic shock, traumatic brain injury, cardiopulmonary bypass 
surgery etc. (Grommes et al., 2011; Han et al., 2015). ALI is marked by increased permeability of 
alveolar-capillary barrier, hypoxemia, activated neutrophil alveolar infiltrates, lung edema, the 
release of chemotactic peptides like IL-8, cytokines (IL-1, IL-6, etc.) and damaging mediators like 
reactive oxygen species (ROS) (Grommes et al., 2011; Williams, 2014). Neutrophils undergo 
degranulation at the site of inflammation, thereby, releasing antimicrobial agents such as ROS, 
proteinases, and cationic peptides (Grommes et al., 2011; Williams, 2014). During migration, 
proteinases aid in degrading the extracellular matrix. Neutrophils are the primary line of defense 
against external injury in ALI. However, excessive neutrophil recruitment, and activation to the 
site of inflammation can lead to further tissue damage. Researchers have shown that the neutrophil 
concentration in the bronchoalveolar lavage fluid (BALF) is correlated with the severity of ARDS 
in ARDS patients (Grommes et al., 2011; Han et al., 2015).  
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2.2 Acute inflammation:  
 
Inflammation is the immune response to tissue injury due to infection or physical damage. The 
damage is detected when the Toll-like receptors (TLRs) and nucleotide binding domain and 
leucine-rich-repeat-containing receptor (NOD-like receptors or NLRs) recognize pathogen-
associated molecular patterns (PAMPs), such as, lipid A domain in bacterial lipopolysaccharides  
(LPS) and damage-associated molecular patterns (DAMPs) (Medzhitov, 2008; Ashley, 2012; Han 
et al., 2015). Lipopolysaccharide (LPS) is the essential constituent of the outer membrane of gram-
negative bacteria, and LPS’s primary structure contains three portions, lipid A, core sugar, and O 
antigen (O-polysaccharide). LPS is amphipathic due to its hydrophilic polysaccharide and 
hydrophobic lipid moieties. Lipid A comprises 4-7 fatty acid chains bound to two glucosamines, 
and core oligosaccharide contains eight carbon sugar, heptose and keto-deoxyoctulosonate (KDO), 
that is highly conserved among bacterial species. 
Lipopolysaccharide (LPS) triggers immunological response by binding to the surface molecular 
receptors present on the immune cells, which initiates a cascade of intracellular signals, leading to 
activation of nuclear transcription factors (Inagawa et al., 2011). TLR4 recognizes LPS which is 
found on the outer surface of most of the gram-negative bacteria (Alexander. C., 2001; Han et al., 
2015). Tissue-resident macrophages and mast cells are the mediators of this recognition of damage, 
and lead to the expression of pro-inflammatory cytokines, like tumor necrosis factor-alpha (TNF-
α), IL-6, IL-12, Interferon gamma (IFN-γ), interleukin-1-beta (IL-1β) (Alexander. C., 2001; 
Ashley, 2012). Researchers conducted an ex vivo study to understand the cytokine kinetics in 
human lung tissues challenged with LPS (100 ng/mL) to induce an acute inflammatory response 
(Hackett et al., 2008). Lung tissues were obtained from subjects with COPD. Cytokine levels were 
determined by performing ELISA on the lung tissue culture supernatant following LPS challenge. 
Supernatant samples were collected at several time points post-LPS challenge. Time points 
included were in the range of 0-24 hours post-LPS challenge. A critical pro-inflammatory cytokine 
is TNF-α, which is released predominantly by macrophages and monocytes, increased starting from 
1-hour post-LPS challenge and peaked at 6-hour time-point. TNF-α plays a vital role in responding 
to host injury by beginning an immune/cytokine cascade. Levels of pro-inflammatory cytokines 
IL-6 and CXCL8 (IL-8) peaked later than those of TNF-α, at 48 hours and 24-hour time-point post-
LPS challenge. CXCL8 (IL-8) is an essential chemotactic factor and plays a role in the development 
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of ALI. However, mice do not have a gene for CXCL8, but they have KC and MIP-2. KC and MIP-
2 are considered functional homologs of human CXCL-8 since they play an essential role in the 
neutrophils' recruitment into the lungs (Matute-Bello, 2008 ). No changes were observed in IL-1β 
levels for LPS-challenge group compared with the control group. IL-10, which is the crucial anti-
inflammatory cytokine, primarily acts on macrophages, neutrophils, mast cells, and eosinophils. 
IL-10 can inhibit transcription of genes encoding pro-inflammatory cytokines like TNFα, IL-6, IL-
8, IL-12, and IL-1. NF-κB activates the gene transcription for cytokines mentioned above. IL-10 
levels increased throughout 48 hours window and peaked at 48 hours post-LPS challenge. IL-5 
levels were not significantly different in the two groups.  
Along with chemokines and costimulatory molecules, the proinflammatory cytokines facilitate the 
recruitment of effector cells (like neutrophils and monocytes) to the site of damage (Ashley, 2012; 
Maas et al., 2018). Neutrophil extravasation takes place via activated endothelia of blood vessels. 
Neutrophils undergo degranulation to release toxic chemicals like reactive oxygen species (ROS), 
reactive nitrogen species (RNS) and proteinases, thereby creating a cytotoxic environment (Ashley, 
2012). These substances are damaging to pathogens as well as host tissue. These interactions 
manifest in the form of cardinal signs of local inflammation that is, heat, redness, swelling, pain, 
and loss of function.  Inflammation must be resolved to achieve tissue homeostasis and limit tissue 
damage, and macrophages lead the process of resolution. These cells switch to producing lipoxins 
to stop further neutrophil recruitment and enhance healing by monocyte infiltration (Ashley, 2012). 
 
2.3 Animal models of ALI/ARDS: 
 
ALI is marked by increased permeability of alveolar-capillary barrier, hypoxemia, activated 
neutrophil alveolar infiltrates, lung edema, the release of cytokines and chemokines. Due to 
difficulty of controlling several clinical variables in critically ill patients, it has been hard to test 
hypotheses about mechanisms of initiation and propagation of lung injury. Animal models provide 
a way to study mechanisms in an intact living system. While there are no perfect animal models 
that can capture human ALI/ARDS in all its complexity, there are many animal models available 
which can provide information on a subset of crucial elements of the disease response in humans 
(Matute-Bello, 2008 ). While the American-European consensus conference defines acute lung 
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injury in humans as an acute onset, a partial pressure of arterial oxygen to fraction of inspired 
oxygen ratios (PaO2/FIO2) of less than 300 mm Hg, presence of bilateral alveolar infiltrates on chest 
radiograph and a pulmonary artery wedge pressure (PAWP) less than 18 mm Hg or no clinical 
evidence of left atrial hypertension, these criteria are very difficult to translate in animal models. 
This is due to unavailability of equipment required for these measurements in small animals in 
most laboratories (Matute-Bello et al., 2011). Therefore, a committee organised by the American 
Thoracic Society concluded that in order to determine if ALI is present, at least three of the four 
key features, which include histological evidence of tissue injury, alteration of the alveolar 
capillary barrier, presence of an inflammatory response, and evidence of physiological dysfunction, 
should be present (Matute-Bello et al., 2011).  
Some of the commonly used models are listed below (Matute-Bello, 2008 ): 
LPS: A reproducible model which induces a neutrophilic inflammatory response similar to ARDS, 
with an increase in intrapulmonary cytokines. However, shows higher species-specific variability, 
whereby rodents require a higher dose (mg/kg range) to develop lung injury response as opposed 
to humans, pigs or cats (μg/kg range). This is due to a lack of pulmonary intravascular macrophage 
in mice. LPS challenge also does not cause severe endothelial or epithelial damage in mice that 
occurs in humans with ARDS. 
Intratracheal bleomycin: This model is most commonly used for studying pulmonary fibrosis. 
However, it is also used as an ALI model since it induces an acute inflammatory response which 
is followed by reversible fibrosis. 
Hyperoxia: The features it has in common with ARDS are the acute epithelial injury and neutrophil 
infiltration which is followed by proliferation of type II cells and scarring. 
Mechanical ventilation: This model is highly clinically relevant due to the changes it has resulted 
in clinical practice. However, it is complex and small animals like mice can not be ventilated for 
longer periods of time.  




Pulmonary ischemia/reperfusion: This method requires complex animal surgery and it results in a 
higher lung vascular permeability with neutrophil infiltration into the lungs, which is a feature of 
ARDS.  
Acid aspiration: Humans can develop ARDS following aspiration of gastric contents. HCl is 
instilled intratracheally while the animal like mouse is mechanically ventilated. ARDS 
characteristics like alveolar/capillary barrier disruption and neutrophil infiltration are reproduced 
in this model. 
Intravenous bacteria: This model shows interstitial edema, congested vasculature as well as 
neutrophil sequestration, which are also observed in ARDS. 
Intrapulmonary bacteria: Neutrophil alveolitis can be observed in this model which is minimal in 
intravenous bacteria challenge. Other characteristics of ARDS share by this model are increased 
vascular permeability and interstitial edema 
Surfactant depletion by saline lavage: This model lacks ARDS features like impaired permeability 
and neutrophil recruitment into the lungs, however, it does cause surfactant depletion and gas 
exchange impairment.  
In this study, we have used a mouse model and administered intranasal LPS (50 µL/mice) from 
Escherichia coli O55:B5 (diluted in sterile saline at 1 g/L). LPS model is highly reproducible and 
shows neutrophilic inflammation response as well as increase in intrapulmonary cytokines which 
are similar to ARDS. However, alveolar-capillary permeability does not show drastic change unlike 
that of in ARDS (Matute-Bello, 2008 ). Mice do not express IL-8 but they have KC chemokine, 
which is a mouse homologue of human IL-8. IL-8 is induced by pro-inflammatory cytokines TNF-
α, IL-6, IFN-γ, TNF-α and IL-1β and acts as a neutrophil chemoattractant (Brat et al., 2005; Matute-







2.4 Cell migration during inflammation: 
 
2.4.1 Leukocyte migration to the site of inflammation: 
 
2.4.1.1 Leukocyte Recruitment Cascade:  
 
Leukocyte migration is a multi-step process composed of steps such as capturing, rolling, adhesion, 
activation, and movement across the endothelium (Muller, 2013; Williams, 2014). The blood flow 
rate decreases in post-capillary venules at the site of inflammation thereby increasing the 
probability of leukocytes encountering the endothelium. Inflammatory cytokines activate the 
endothelial cells, and activated endothelial cells express several molecules on their surface to allow 
leukocyte migration. P-selectin expressed on the luminal surface of activated endothelial cells 
interacts with selectin ligands such as P-selectin glycoprotein 1 (PSGL-1) on the leukocytes 
(Muller, 2013). Inflammatory response results in the release of chemokines by endothelial cells, 
and resident inflammatory cells. These chemokines activate leukocyte integrin αLβ2 (also known 
as leukocyte function-associated antigen-1, LFA-1) via G protein-coupled receptors. LFA-1 binds 
to the intercellular adhesion molecule-1 (ICAM-1) and intercellular adhesion molecule-2 (ICAM-
2) on endothelium (Ley et al., 2007; Muller, 2013). L-selectin was recently shown to play major 
role in regulation of circulating leukocyte activation in vivo (McEver, 2015; Liu et al., 2017). Liu 
et al. showed that circulating leukocytes were primed (slightly activated) in mice expressing an L-
selectin mutant and primed peripheral blood neutrophils from these mice released high amounts of 
ROS in-vitro. However, the cytokine and chemokine levels in plasma remained normal in the L-
selectin mutant mice. The L-selectin mutant mice did not develop hypothermia because of prompt 
removal of injected E. coli from the peritoneum (Liu et al., 2017). The adhered leukocytes continue 
moving along the endothelium in crawling motion to the site of extravasation. In response to MIP-
2 and TNF-α, Mac-1 on leukocytes interact with ICAM-1 on endothelial cells, to achieve 
intraluminal crawling (Phillipson et al., 2006; Muller, 2013). All the above steps are reversible, 
and leukocyte can return to the circulation at any point. Followed by firm adhesion and crawling, 
the leukocytes move across the endothelium to reach the site of inflammation. This process is called 
transendothelial migration. In an IL-1β model of inflammation in mice, disruption of PECAM-1 
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(CD31), CD99 and CD99L2 caused the arrest of migrating leukocytes at the basement membrane 
level (Bixel et al., 2010; Sullivan et al., 2014). VE-cadherin negatively regulates transmigration. 
Various anatomical features of the transmigratory cup or dome have been reported (Phillipson et 
al., 2008; Petri et al., 2011). Membrane at the endothelial cell borders is internalized and recycled 
by a compartment known as lateral border recycling compartment (LBRC). LBRC lies beneath the 
plasma membrane of the endothelial cell borders. LBRC contains PECAM and CD99. However, 
VE-cadherin is absent from this compartment (Muller, 2013). During leukocyte transmigration, 
LBRC membrane has been observed to be targeted at the location of transmigrating leukocyte 
(Mamdouh et al., 2003; Mamdouh et al., 2008; Muller, 2013). This redirection has been shown in 
vitro to be achieved by kinesin molecular motors along microtubules (Mamdouh et al., 2008; 
Muller, 2013).  
 
2.4.1.2 Cytoskeletal Dynamics during Cell Migration: 
  
Migrating leukocytes fall under the amoeboid-moving category. It involves cortical actin networks 
which are composed of branched actin filament sheets running parallel with the plasma membrane 
(Boekhorst, 2016). Dynamic filamentous actin (F-actin) cytoskeleton drives the physical behavior 
of migrating cells. The F-actin cytoskeleton is coupled to the extracellular matrix (ECM) via focal 
adhesions (FAs). FAs are dynamic assemblies of signaling proteins which are crucial for regulating 
cellular structure (Gardel, 2010). Rho family GTPases are essential regulators of FAs. 
Chemoattractant provides directional signals which induce the development of random pseudopods 
on neutrophils. These pseudopods allow migration of activated neutrophils into inflamed organs 
(Insall, 2010; Insall, 2013). Migration of neutrophils is guided by the leading edge, which is an 
extension of the main pseudopod. Aggregation of filamentous actin takes place to support this 
extension. G-protein coupled receptors (GPCRs) bind to chemoattractant. GPCRs signal through 
βγ subunits via GTP-bound small G-proteins like Rac, Rho, and cdc42. Activation of mitogen-
activated protein kinases (MAPK) and phosphatases takes place downstream of the Rho family of 
GTP-binding small G proteins (Niggli, 2003). Besides, neutrophil activation takes place through 
the p38 MAPK pathway during endotoxemia (Khan et al., 2005). During these events, heat shock 
protein (HSP)-27 phosphorylation leads to destabilization of the microtubule complex to favor the 
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formation of a significant protrusion in vitro and a pseudopod in vivo (Hino et al., 2000; Hino et 
al., 2003; Jog et al., 2007). The trailing edge is called the uropod. The intracellular cytoskeletal 
elements are intricately linked to adhesive proteins such as integrin and selectins expressed on the 
surface of neutrophils (Barreiro et al., 2007; Ley et al., 2007; Barreiro et al., 2010). Endothelial 
cell shape is maintained by cytoskeletal actin, vimentin and cortical actin linkers like ERM (ezrin, 
radixin, and moesin) proteins (Niggli, 2003; Niggli et al., 2008). 
 
 
2.4.2 Neutrophil recruitment into the lung: 
 
The typical steps of neutrophil rolling, adhesion and transmigration are not well characterized in 
the lungs largely because of the challenges of application of intravital microscopy. There actually 
is scant evidence of neutrophils actually migrating out of the alveolar capillaries in the lung. The 
microenvironment in the lungs requires neutrophils to change shape for transiting through the 
capillary lumen which is about 5-7 micron wide and for migrating through capillary endothelium 
and alveolar epithelium. As indicated in the prior sections, neutrophil migration involves a plethora 
of molecules including cytokines, adhesion molecules, cell signaling molecules, structural proteins, 
etc. Neutrophil migration in the lungs is different from the generally accepted leukocyte 
recruitment paradigm for several reasons. First, the narrow diameter and twisting nature of the lung 
capillaries result in retention of a large number of neutrophils (Doerschuk, 1990; Hellewell, 1994). 
Second, the pulmonary vasculature is a lower blood pressure region compared to the peripheral 
vasculature. Finally, depending upon the microbial stimulus for the inflammation, the recruitment 
appears to be independent of selectins and β2-integrins due to equivocal reports (Doerschuk, 1990; 
Windsor AC, 1993; Hellewell, 1994). Currently, there is a need to identify additional molecules 











The CD34 protein belongs to a family of single-pass transmembrane sialomucin proteins. 
Glycosylated CD34 has a molecular weight of 90-120 kDa. CD34-family incorporates 
hematopoietic progenitor cell antigen CD34, podocalyxin, and endoglycan (Sassetti et al., 2000). 
These CD34-family proteins have a serine-, threonine- and proline-rich extracellular domain that 
is expansively O-glycosylated and sialylated. The extracellular part of these proteins also includes 
a cysteine-bonded globular domain and a juxtamembrane stalk, also putative N-linked 
glycosylation site. Each of these proteins contains a single transmembrane helix along with a highly 
conserved cytoplasmic tail that contains phosphorylation sites and a C-terminal PSD-95—D1g-
ZO-1 (PDZ)-domain-binding motif. CD34 is glycosylated only in high endothelial venules (HEV) 
in secondary lymphoid organs, to allow binding of L-selectin expressed on lymphocytes (Rosen, 
2004; Nielsen, 2008). CRKL, a member of the Crk family of adapter proteins, is an intracellular 
ligand for CD34. They contain one Src-homology 2 (SH2) domain (phosphotyrosine-binding) and 
two Src-homology 3 (SH3) domains (proline-rich-sequence-binding). Crk protein links proteins 
that do not have intrinsic kinase activity to intracellular signaling cascades, thereby enabling them 
to transmit signals indirectly (Nielsen, 2008).  
 
2.5.2 CD34 expression:  
 
CD34-family proteins are proposed to play various roles depending on the site of expression 
(Nielsen, 2008). The cell surface protein CD34 has been reported in multiple human tissues and 
cells. Two-color FACS was used to isolate CD33-CD34+ cell population from hematopoietic stem 
cells (Andrews, 1989). Long-term marrow cultures of CD33-CD34+ cells generated colony forming 
cells for more than five weeks. Vascular endothelial cells (Fina et al., 1990; Pusztaszeri et al., 
2006), mucosal dendritic cells (Blanchet, 2011), mast cells (Drew, 2002), eosinophils (Radinger et 
al., 2004; Blanchet et al., 2007), microglia (Ladeby et al., 2005), fibrocytes (Schmidt, 2003), 
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muscle satellite cells (Beauchamp et al., 2000) and inactivated platelets (Lewandowska et al., 2003) 
have been shown to express CD34. Fibroblast-like cells situated in the submucosa flanked by 
SMA+ smooth muscle cells of the muscularis mucosae and the muscularis propriae have stained 
positive for CD34. CD34 was also expressed in the lamina propria’s endothelial cells in the caecum 
of C57Bl/6 mice (Grassl et al., 2010). In dogs, CD34 expression has been observed in the 
hematopoietic stem cell in bone marrow (Suter et al., 2004), peripheral blood (Tsumagari et al., 
2007) and hair follicle (Kobayashi et al., 2009).  
 
2.5.3 Functions of CD34-family proteins: 
 
CD34 is glycosylated only in high endothelial venules (HEV) in secondary lymphoid organs 
(except for spleen which lacks HEVs), to allow binding of L-selectin expressed on lymphocytes 
(Rosen, 2004; Nielsen, 2008). CD34 has been reported to bind all three selectins namely L-selectin 
(CD62L), E-selectin (CD62E) and P-selectin (CD62P) (Felschow et al., 2001; Alfaro et al., 2011; 
Ohnishi et al., 2013; AbuSamra et al., 2017). Platelets have been shown to bind to anti-CD34-
coated expanded polytetrafluoroethylene vascular grafts (Mrówczyński et al., 2014). The 
contribution of CD34 in lymphocyte tethering and rolling has been shown in vitro using laminar 
flow assays (Puri et al., 1995). CD34 forms close to 30% of the total protein in peripheral node 
addressin (PNAd) which is comprised of several glycoproteins and plays a role in lymphocyte 
homing by showing L-selectin ligand activity in the tonsillar stroma. The CD34 rich fraction of 
PNAd demonstrated about half the total binding activity. CD34 was also isolated from spleen and 
KG1a hematopoietic cell line. The CD34 fraction from spleen did not show lymphocyte tethering 
since lymphocyte homing in the spleen is L-selectin independent. CD34 from KG1a hematopoietic 
cell line was also functionally active as an L-selectin ligand. All forms of CD34 actively bound to 
E-selectin (Puri et al., 1995).  
In the absence of HEV-specific glycosylation elsewhere, negatively charged and large extracellular 
domains of CD34 may create repulsion and steric hindrance. This repulsion and steric hindrance 
can prevent interaction of integrin on endothelium with their ligands on lymphocytes, thereby 
blocking cell adhesion. Delia, et al. observed CD34 expression in a diffused cell surface pattern in 
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freshly cultured vascular endothelial cells, with some concentration on microvilli. Interleukin-18 
(IL-18), interferon-y (INF-y), and tumor necrosis factor-a (TNF-a) downregulated CD34 
expression at mRNA as well as protein level. These molecules upregulate adhesion molecules like 
endothelial leukocyte adhesion molecule (ELAM-1) and intracellular adhesion molecule 1 (ICAM-
1). CD34 has been implicated in the negative control of endothelial adhesion due to this reversed 
pattern of expression  (Delia et al., 1993). Forced expression of CD34 induced cell rounding, 
microvillus formation, and phosphorylation of ezrin/radixin/moesin (ERM) proteins in HEK293T 
cells while inhibiting integrin-mediated cell re-attachment to HEK 293T cells (Delia et al., 1993; 
Ohnishi et al., 2013). ERM proteins act as a crosslink between actin filaments and plasma 
membrane. These proteins co-localize and associate with CD44 through N-terminal domain and 
with actin through C-terminal domain (Mori, 2008). CD34 does not interact with the NHERF 
ligands (PDZ-family proteins ezrin-radixin-moesin-binding phosphoprotein 50) unlike 
podocalyxin (Haslett, 1999; Tan et al., 2006).  
CD34’s role on vascular endothelial cells is supported by results in the study where B16 melanoma 
tumor development was shown to be affected by the expression of CD34 in mice (Maltby et al., 
2011). Fourteen days after subcutaneous injection of B16F1-OVA cells in WT CD34+/+ C57Bl/6 
mice and CD34 KO mice,  there was a significant tumor size difference between CD34 KO mice 
and WT CD34+/+ mice (measured using manual calipers), with tumor size being more prominent 
in the WT CD34+/+ mice compared to the CD34 KO mice (Maltby et al., 2011). This difference in 
early tumor development at day 14 via subcutaneous injection in CD34 KO mice and WT mice has 
been attributed to the CD34 expression difference in the two groups in non-hematopoietic cells 
(mostly mast cells and eosinophils) rather than CD34 expression in hematopoietic cells (Maltby et 
al., 2011). Bone marrow reconstituted chimeras were used to that end. When the mice from both 
groups were irradiated and with bone marrow reconstituted from WT Ly5.1 congenic mouse, the 
resultant chimera expresses WT CD34 on hematopoietic lineages; however, the state of CD34 
expression on non-hematopoietic cells remains unchanged. 14 days after subcutaneous injection, 
tumor volume measurements showed that CD34 KO mice reconstituted with bone marrow from 
WT mice had a smaller sized tumor, in comparison to CD34+/+ mice reconstituted with bone 
marrow from WT animals.  Also, twelve days after injecting B16F2-OVA cells intravenously, there 
were less metastatic lung nodules in CD34 KO mice in comparison to WT mice (Maltby et al., 
2011). CD34 also affected the tumor vascular integrity as studied by using fluorescent dye, 
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carbocyanine, assay. CD34 KO mice had significantly higher vascular leakage of the dye compared 
to the WT control (Maltby et al., 2011). Above phenotypes support role of CD34 role in functioning 
of vascular endothelial cells. These are in line with the results of other studies which shed light on 
CD34's role in sustaining vascular integrity in embryonic growth as well as inflammatory disease 
(Strilić et al., 2009; Blanchet et al., 2010) An increase in tumor growth as well as reduction in intra-
tumoral infiltration of mast cell was observed in CD34 KO mice at a later time-point of 19 days. It 
has also been shown that eosinophils display anti-tumor activity (Simson et al., 2007)  and that 
CD34 plays an essential part in the migration of eosinophils (Blanchet et al., 2007). Hence, the 
tumor growth at later stages in CD34 KO can be attributed to decreased migration of eosinophils 
which might result in lesser anti-tumor growth activity (Maltby et al., 2011) 
CD34 has an important role in the ability of peripheral blood-derived endothelial colony-forming 
cells (ECFCs) to form capillary-like tubes, and their barrier integrity (Tasev et al., 2016). Magnetic 
sorting of sub-cultured ECFCs was performed to select CD34- and CD34+ ECFCs (FACS: - 
CD34+: 95% positive; CD34-: 99% negative). Proliferation rate was the same for both CD34- and 
CD34+ ECFCs as calculated from the pictures taken using phase contrast microscopy (visualizing 
cell nuclei in 2% paraformaldehyde/HBSS fixed cells using DAPI). 3D human fibrin matrices were 
used to seed the two cell populations, and these cell cultures were then stimulated with vascular 
endothelial factor-A and fibroblast growth factor-2 (FGF-2) to induce tube development. The tube-
forming capacity of CD34+ ECFCs was significantly more than that of CD34- ECFCs. CD34 
silencing with siRNA in ECFC monolayers led to stronger cell-cell contacts and improved barrier 
function as determined by electric cell-substrate impedance sensing measurements. ECFCs also 
showed less tube development when CD34 was silenced (Tasev et al., 2016). 
An early study showed that forced expression of the full-length CD34 protein in M1 myeloid 
leukemia cells inhibited their terminal differentiation when treated with differentiation-inducing 
agent interleukin-6 (Fackler et al., 1995). This effect was not observed when truncated form of 
CD34 lacking part of the cytoplasmic tail domain was force expressed instead, suggesting that 
CD34 exerts a differentiation blocking impact in hematopoietic cells through the cytoplasmic tail 
region. CD34 gene in humans and mice is highly conserved in the intracellular region with greater 
than 90% amino acid identity which points towards a common and essential function of this region 
as a differentiation blocker across species (Fackler et al., 1995).  
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Marone et al. used flow cytometry to observe that CD34 was transcriptionally activated in 
hematopoietic cell lines such as CD34+ TF-1, CD34+ KG-1a by exogenous transforming growth 
factor β1 (TGF- β1). TGF- β1 also stopped cells in early progenitor stage (CD34+ TF-1 cells) from 
differentiating. The study presented data implicating CD34’s involvement in the anti-
differentiating role of TGF- β1 (Marone et al., 2002). 
CD34 has also been shown to play an essential role in skeletal muscle regeneration mediated by 
satellite cells (Alfaro et al., 2011). Notexin was injected to induce acute damage in mice, to study 
the role of CD34 in skeletal muscle regeneration. At time points of 0, 5, 10, 14 and 21 days post-
notexin injection, Tibialis anterior muscles were harvested from adult CD34 KO and WT mice. 
Upon H&E staining of the paraffin-embedded tissue, the areas of damage were measured by using 
images taken with a light microscope and calculating density slices using OpenLab software 
(version 4.0.4). The measurements revealed that at 5-day time-point, size of damaged areas was 
not much different in CD34 KO vs. WT mice. However, the necrotic myofibers were significantly 
higher in number in CD34 KO mice in comparison to WT mice. Also, a delay was seen in the 
appearance of centrally nucleated fibers (typical of regenerating myofibers). The centrally 
nucleated fibers in WT animals were significantly bigger than that of CD34 KO mice, whereas the 
undamaged fibers were not much different, as determined by cross-sectional area measurements. 
These data suggest that despite being able to initiate repair, the regenerating fibers in CD34 KO 
mice failed to undergo hypertrophy (a crucial part of myogenesis) (Alfaro et al., 2011). At day-3 
post damage, CD34 was found to be down-regulated on the myogenic progenitor cells (MPCs) as 
determined using FACS analysis and lost by day-5. MPCs start to show CD34 re-expression on the 
surface at day-10, which is right after their proliferation stops. The total CD34 mRNA down-
regulation shortly post-damage was established using quantitative real-time PCR. Thus, suggesting 
CD34s’ role as a differentiation blocker in MPCs which is supported by other studies (Beauchamp 
et al., 2000; Ieronimakis et al., 2010; Alfaro et al., 2011). 
CD34 plays a crucial role in advancing MPCs and satellite cells over the initial steps of myogenic 
progression, which would be the time from the start of injury to the start of satellite cell division 
(Alfaro et al., 2011). Some of the critical events that happen throughout this period have been 
shown to be affected by CD34. Firstly, satellite cells cross the basement membrane, thus exiting 
the niche. Apparently, cells need to be motile for exiting the niche. Live imaging of single fibers 
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from CD34 KO and WT animals showed that CD34 KO satellite cells moved slower and traveled 
smaller distance in comparison to the WT satellite cells. However, the difference between the 
percentage of CD34 KO and WT satellite cells located above and below basement membrane was 
negligible, as studied using confocal microscopy of the relative position of Pax7+ satellite cells on 
the laminin+ basement membrane and cultured fibers. Thereby, showing that the even though 
CD34 KO satellite cells demonstrate ineffective motility, it does not hamper them from exiting the 
niche. Lastly, the proliferation of myogenic cells starts, and CD34 has been shown to be critical 
for satellite cells’ effective entrance into the proliferation stage. Pax7 and MyoD expression were 
measured in single fiber cultures to look at the satellite cells’ movement through the myogenic 
process. Inactive satellite cells show high expression of Pax7. However, these cells begin to express 
MyoD upon entering the cycle and ultimately Pax7 is down-regulated while committing to 
differentiation. Differentiation-committed myoblasts (Pax7- MyoD+) were absent in CD34 KO 
fibers at 48-hour time-point in culture compared to their presence in WT fibers. After 72 hours of 
culture, the frequency of these myoblasts is observed to be significantly lesser in CD34 KO fibers 
compared to the WT fibers. Hence, satellite cells lacking CD34 experience postponement while 
progressing through the myogenic program (Alfaro et al., 2011). 
CD34 has been shown to facilitate inflammation by affecting neutrophil recruitment in the 
intestines of mice infected with S. Typhimurium (Salmonella) (Grassl et al., 2010). Upon oral 
streptomycin pretreatment and challenge with S. Typhimurium, CD34 KO mice had milder caecal 
inflammation compared to C57/Bl6 WT mice, as evident from the caecal contents of WT mice 
which were full of infected exudate at day-5 post-infection compared to brown-colored feces of 
CD34 KO mice at day-5. Caecal weights, which is inversely correlated to inflammation, were 
significantly lighter in infected WT mice compared to infected CD34 KO mice, showing that CD34 
KO mice mount a weaker inflammatory response as compared with WT mice. H&E staining 
revealed that the caecum of WT mice had severe changes in pathology day-2 post-infection, with 
necrotic epithelial cells occupying the lumen, damaged crypt architecture, and extensive edema in 
the submucosa. Whereas, caecum of CD34 KO was not as inflamed: feces occupied the lumen, 
necrotic cells were scarce, and integrity of crypt architecture was mostly maintained, despite the 
invasion of the mucosa by inflammatory cells. Five days after infection, caecum of the WT mice 
was in a serious pathological state as the necrotic epithelial cells, and polymorphonuclear 
neutrophils were closely packed within the lumen, and inflammatory cells completely changed the 
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mucosal architecture. Whereas the lumen in CD34 KO mice caecum did not show many necrotic 
cells, and polymorphonuclear neutrophils, however, the mucosal structure did show severe changes 
like mucinous plugs, and crypt abscesses (Grassl et al., 2010). No difference was observed in the 
bacterial loads in two groups, thereby, suggesting that attenuated caecal inflammation in CD34 KO 
was due to the difference in the host inflammatory responses rather than the capacity to regulate 
the S. Typhimurium infection. Neutrophil recruitment after two and five days after infection with 
S. Typhimurium was significantly delayed in CD34 KO mice caecum as compared to WT mice 
caecum. The analysis was carried out using H&E staining, naphthol AS-D acetate esterase staining 
which highlights granulocytic cells like neutrophils and mast cells, and myeloperoxidase 
immunostaining, since neutrophils express a high amount of myeloperoxidase (Grassl et al., 2010).  
In a mouse model of ulcerative colitis induced orally by dextran sulfate sodium (DSS), CD34 
deficient mice showed significantly lesser colitis as compared with WT mice (Maltby et al., 2010). 
Flow cytometric analysis revealed that colon tissue of DSS-challenged WT mice had a significantly 
higher percentage of CD34 expressing eosinophils than CD34 KO mice. Furthermore, 
immunostaining against the eosinophil-specific major basic protein (MBP) showed that WT mice 
colon had a higher number of infiltrating eosinophils than the CD34 KO mice colon tissues on day-
8 post-DSS administration. The bone marrow chimera experiments, whereby WT mice received 
the CD34 KO bone marrow, showed less colitis which was comparable to the response of CD34 
KO mice to DSS treatment. Thereby, demonstrating the importance of expression of CD34 in 
eosinophils, which have a hematopoietic origin, in colitis development (Maltby et al., 2010). 
Podocalyxin is a CD34-family protein and has been shown to be expressed in the vascular 
endothelia of rat lungs using immunohistochemistry (Tschernig et al., 2014). Previous studies using 
immunofluorescence and flow cytometry  suggest expression of podocalyxin on the surface of 
activated rat platelets (Miettinen et al., 1999).  Podocalyxin is also involved in the thrombogenic 
potential of platelets, and activated platelets are crucial in recruiting neutrophil in the vasculature 
during inflammation (Ma et al., 2008; Tschernig et al., 2014). It is an essential membrane protein 
of the glomerular epithelium and is necessary for the development of the kidney. In the 
developmental stage, Podxl-/- mice did not form foot processes because of their inability to soften 
tight junctions (Doyonnas et al., 2001). Takeda et al. used cell aggregation assay to show that 
podocalyxin functions as an anti-adhesion molecule and maintains an open filtration pathway 
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between adjacent foot processes in the glomerular epithelium by charge repulsion. Cell adhesion 
properties of transfected Chinese hamster ovary (CHO)-K1 and Madin-Darby canine kidney 
(MDCK) cells were studied with the help of cloned rat podocalyxin. CHO-K1 cells expressed high 
levels of podocalyxin, and showed complete inhibition of cell aggregation, and MDCK 
transfectants showed significantly decreased collection (∼60–80%) compared with parental cells 
(Takeda et al., 2000). 
Debruin et al. used a conditional knock-out mice model to show that podocalyxin expression in 
lung endothelial cells was responsible for the maintenance of vascular integrity. The selective 
deletion of podocalyxin in vascular endothelial cells (PodxlΔEC) using Cre-lox system under the 
control of Cdh5 (VE-cadherin) promoter led to higher lung volume as well as higher levels of 
elastin-free collagen fibrils which point towards irregular lung growth in adult mice.  Upon using 
Evan’s blue dye vascular leakage assay, they found that PodxlΔEC mice lungs had significantly 
higher vascular permeability as compared to the control group mice, this difference magnified after 
LPS-induced lung inflammation. However, no apparent change in lung edema, vascular density or 
endothelial cell frequency was observed. The higher lung vascular permeability in PodxlΔEC mice 
can be attributed to abnormal laminin-dependent cell-matrix interactions as studied by plating the 
isolated endothelial cells on protein (collagen I, fibronectin or laminin) coated plates 90 min (static 
adhesion assay) or with protein coated well inserts for 48-hours (cell spreading assay) (Debruin et 
al., 2014). 
In a recent study, Cait et al. used electrical cell substrate impedance sensing and live imaging to 
show that the human umbilical vein endothelial cells with siRNA silenced podocalyxin fail to form 
an efficient barrier when plated on extracellular matrix substrates. They also lacked adherence 







2.6 CD34 and lung inflammation: 
 
Mucosal dendritic cells have been shown to express CD34. CD34 KO DCs were unable to present 
antigen to T cells while preserving the innate inflammatory response (Blanchet, 2011). The 
researchers found that dendritic cells purified from the spleen of CD34 KO mice displayed 
defective migration in response to the chemotactic gradient (Blanchet, 2011). Ultimately, CD34 
KO mice which were enabled with the human CD34 transgene expression gained the ability to 
develop hypersensitivity pneumonitis. In this murine hypersensitivity pneumonitis (Th1/Th17-
dependent disease) model, CD34 KO mice were protected against the development of 
hypersensitivity pneumonitis.  
In a mast cell and eosinophil-dependent asthma (Th2-dependent) model, eosinophils from CD34 
KO mice show significantly less pulmonary migration compared with eosinophils from WT mice. 
CD34 KO and WT mice mount a comparable immune response. CD34 KO mice were resistant to 
allergic asthma development in this model. The data suggest that CD34 plays a vital role in the cell 
trafficking by acting as an anti-adhesive or pro-adhesive molecule, depending on the cell and tissue 
type (Blanchet et al., 2007). 
Lo et al. showed that mice lungs lacking CD34 expression on the non-hematopoietic cells 
demonstrated higher sensitivity to bleomycin-induced lung injury. CD34 KO mice experienced 
extreme weight loss as well as early mortality compared to WT mice when challenged with 
bleomycin endotracheally. The response to was dose-dependent. At an early time point of three- 
and six-days post-bleomycin challenge, no difference was observed between the two groups in the 
total CD45+ leukocyte counts in the bronchoalveolar lavage fluid, or in the proinflammatory 
cytokine levels (IL-1β, CXCL1, IL-6, and TNF-α) in the lung tissues. However, Miles assay 
revealed that CD34 KO mice lungs experienced higher vascular leak than the WT mice six days 
after bleomycin challenge. Ultrastructural analysis using transmission electron microscopy (TEM) 
revealed exposed collagen in the interstitium suggesting widespread interstitial edema and 
delamination of the endothelium in the mice lungs lacking CD34. Thereby implicating CD34 in 
alveoli’s structural integrity maintenance (Lo et al., 2017).   
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Nevertheless, to my knowledge, only one report is available on the expression and role of CD34 in 
neutrophil recruitment during acute lung inflammation (Lo et al., 2017). Considering the role of 
CD34 in cell shape and attachment (Delia et al., 1993; Ohnishi et al., 2013), and its role in leukocyte 
recruitment in allergic (Blanchet et al., 2007) and hypersensitivity models (Blanchet, 2011), it is 
hypothesised that CD34 KO mice will show altered vascular permeability, endothelial/leukocyte 
adhesion, and thus, transmigration in response to intranasal endotoxin (Lipopolysaccharide, LPS) 
compared with the WT mice. 
 
2.7 Hypothesis and objectives 
 
Hypothesis: CD34 KO mice will show lower vascular permeability, cytokine and chemokine 
release, and leukocyte transmigration in response to intranasal endotoxin (Lipopolysaccharide, 
LPS) compared with the WT mice 
 
Objectives: To study LPS induced inflammatory response in the lungs of CD34 KO mice 
compared with WT mice 
 
2.8 Rationale for experiments 
 
Given CD34 expression on vascular endothelial cells and leukocytes and only one published report 
on the role of CD34 in acute lung inflammation (Lo et al., 2017), this possible relationship warrants 
further study. Considering the role of CD34 in cell shape and attachment (Delia et al., 1993; 
Ohnishi et al., 2013), and its role in leukocyte recruitment in allergic (Blanchet et al., 2007) and 
hypersensitivity models (Blanchet, 2011), we hypothesized that CD34 KO mice will show lower 
vascular permeability, cytokine and chemokine release, and lower leukocyte transmigration in 
response to intranasal endotoxin (Lipopolysaccharide, LPS) compared with the WT mice. 
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Ten- to twelve-week-old C57BL/6 WT mice were purchased from Charles River (Montreal, QC, 
Canada). CD34 knock-out mice were received from Dr. McNagny lab at University of British 
Columbia and were bred at the Lab Animal Service Unit (LASU, University of Saskatchewan, SK, 
Canada). Age-matched mice were used in all experiments. All experiments were approved by 
University Committee on Animal Care and Supply (UCACS) and Animal Research Ethics Board 
(AREB) of the University of Saskatchewan (Saskatoon, SK, Canada).  
Mice from each phenotype (i.e. WT and CD34 KO) were divided into five sub-groups comprising 
of 0, 3, 9, 15 and 24 h LPS treatment time-points (Fig.3.1). Each time-point had five-seven WT 
mice and five-seven CD34 KO mice. The 0 h time point reflects no LPS treatment. Both male and 
female mice were used for experiments. Each time point contained at least three mice of each 
gender for each phenotype. Sample size calculation was performed using OpenEpi online tool 
(http://www.openepi.com/), with two-sided confidence level (i.e. 1-α) set at 95% and power (i.e 1-
β) set to 80%. The calculation yielded a sample size of 8-13 animals/phenotype (for each time-
point).   
 
3.2 Induction of lung injury:  
 
Mice aged 12- to 16-week were anesthetized by isoflurane inhalation, and LPS (from Escherichia 
coli O55:B5; Sigma-Aldrich, Oakville, ON, Canada) diluted in sterile saline (1 g/L) was 
administered via intranasal route (50 µL/mice). Control mice at 0 h time point did not receive LPS. 
After 3, 9, 15 or 24 h, mice were sacrificed by cardiac puncture under deep terminal anesthesia 
induced by isoflurane. Blood was collected in acid citrate dextrose containing tubes. The blood   
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(100 µL) from each non-coagulated sample was taken to PDS (Prairie diagnostic services, 
Saskatoon, Canada), plasma from rest of the blood sample was stored at -80°C. PDS performed 
total and differential cell counts on the blood samples. Right lung was flash frozen in liquid 
nitrogen and stored in -80°C for MPO estimation to determine lung neutrophil migration. The left 
lung was fixed in 4% PFA, 0.1% glutaraldehyde and paraffin embedded.  




Fig.3.1: Experimental set-up: A schematic of the experimental set-up showing various time 
points of bronchoalveolar lavage (BAL), peripheral blood and tissue collection for various 
downstream assays from WT (N=6-7 per time-point) and CD34 KO (N=6-7 per time-point). The 
left lung was perfused with cold saline to get rid of circulating blood, fixed via tracheal intubation 
with 4% paraformaldehyde and 0.1% glutaraldehyde and paraffin embedded. The frozen tissue 
(using liquid nitrogen), BAL supernatant and plasma were stored at -80°C until further analysis.
WT    N=5-7 
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3.3 Broncho-alveolar lavage (BAL) analysis:  
 
Trachea was exposed through a midline incision and a sterile 23-gauge lavage tube was cannulated. 
Bilateral BAL was performed by instilling 0.5-ml sterile saline, thrice. Cytospin preparations were 
stained with Giemsa to obtain BAL differential cell counts (macrophage, neutrophil, monocyte and 
lymphocyte). Alveolar macrophages are bigger in size compared to monocyte. Thus, we 
differentiated them during counts based on size. The total BAL leukocyte count for each sample 
was calculated by adding the absolute differential counts (macrophage, neutrophil, monocyte and 
lymphocyte).  BAL supernatant was stored at -80°C for cytokine analysis using ELISA. 
 
3.4 Myeloperoxidase assay:  
 
Myeloperoxidase (MPO) estimation was performed to indirectly quantify the number of 
neutrophils left behind in the lung tissue after BAL fluid removal. The right mouse lung sections 
stored at -80°C were mechanically homogenized in 500 μL of 50 mM HEPES (pH 8.0). 
Supernatant was discarded after centrifugation (10,000 g, 20 mins) and the pellet was resuspended 
in 500 μL of 0.5% CTAC. Resuspended pellets were homogenized and were centrifugated, the 
resultant supernatant was aliquoted into new tubes. A standard curve was made by using 
myeloperoxidase from human leukocytes (M6908- 5UN; Sigma-Aldrich). Sample (10 µl) was 
pipetted into separate wells of 96-wells microtiter plates in duplicates. Followed by 65 μL 
phosphate citrate. Lastly, 100 μL of TMB substrate was added and samples were incubated for 5 
min to allow color development. After incubation, 150 μL stop solution was added to each well 
and absorbance were measured at O.D. 450 nm with a spectrophotometer. 
 
3.5 Immunofluorescence staining (IF):  
 
IF was performed to look at the neutrophil marker Gr1 and vWF, which is an endothelium marker, 
in WT and CD34 KO mice across different time-points. Tissue sections were deparaffinized with 
xylene and rehydrated in an ethanol series. Endogenous peroxidase activity was inactivated with 
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0.5% H2O2 in methanol in dark for 20 mins at room temperature. After washing, antigen retrieval 
was performed in two steps. Firstly, heat induced epitope retrieval (HIER) was performed by 
incubating sections in sodium citrate buffer (10 mM, pH 6.0) at 90°C-95°C for 20 minutes. Then, 
the sections were allowed to cool in distilled water, following which the sections were incubated 
with warmed pepsin (2 mg/ml in 0.01 N HCl) at 37°C for 20 min. After washing, they were blocked 
with 1% bovine serum albumin in 1% PBS for 30 min at room temperature. The sections were then 
incubated overnight at 4°C with 100 µL primary antibodies per section against Von Willebrand 
Factor (A0082, 1:300, Dako Denmark A/S, Glostrup, Denmark) and Gr-1 (rat anti-mouse, 1:100; 
550291; BD Biosciences, ON, Canada. Next day, the slides were left at room temperature for 30 
min followed by washing with PBS 1X thrice. After washing, they were incubated with 100 µL 
secondary antibody per section (AF488, green) for 30 min at room temperature (in dark). After 
washing, sections were counterstained with DAPI. Sections were then allowed to dry, and cover 
slips were mounted with Prolong gold mounting medium. Media was then allowed to cure for 24 
hours before sealing the cover slip with nail varnish. Stained slides were stored in dark at 4°C. 
 
3.6 Broncho-alveolar lavage (BAL) total protein estimation assay:  
 
Total protein concentration estimation in the BAL supernatant was performed using a colorimetric 
assay, DC™ Protein Assay (Bio-Rad, DC™ Protein Assay, California, USA). The assay was 
performed to determine the amount of protein in the alveoli which was washed off with BAL. The 
amount of protein in the BAL supernatant is associated with the vascular permeability of the lungs. 
This assay is a modified version of Lowry assay. Standard or samples (5 µl each) of BAL fluid 
were pipetted into separate wells of 96-wells microtiter plates in duplicates. This was followed by 
adding 25 µl of Reagent A’ (1 mL alkaline copper tartrate solution Reagent A + 20 µl surfactant 
solution Reagent S) to each well. Lastly, 200 µl of Reagent B (dilute Folin reagent) was added to 
each well. The samples were incubated for 15 minutes and the absorbance was measured at 750 






3.7 Histology:  
 
Left lung was harvested and fixed in 4% PFA, and 0.1% glutaraldehyde. Lungs were embedded in 
paraffin. Four-micrometer sections were stained with Hematoxylin and eosin (H&E) stain and 
analyzed by a pathologist who was blinded for groups. Lung perivascular, peribronchiolar and 
septal inflammation and damage was analyzed and semi-quantitatively scored. Inflammation levels 
were scored based on congestion, neutrophil infiltration, and endothelial damage. The higher level 
of congestion, endothelial damage and neutrophil infiltration correspond to a higher score for 
overall inflammation. Absence of inflammation was recorded as “0”, minimal inflammation as, 
“1”, moderate inflammation as, “2” and intense inflammation as, “3”.  
 
3.8 Cytokine analysis:  
 
Cytokine studies were performed to characterize the differences in LPS induced inflammation 
among WT and CD34 KO mice. Cytokine levels were studied in BAL fluid supernatant using 
commercially available ELISA kit, Bio-Plex Pro™ Mouse Cytokine 23-plex Assay (#m60009rdpd, 
Bio-Rad, California, USA) which is based on fluorescent multiplex ELISA. The cytokines and 
chemokines included in the panel are TNFα, IL-6, IL-1β, MCP-1, KC, IL-10, IL-1α, IL-2, IL-3, 
IL-4, IL-5, IL-9, IL-12 p40, IL-12 p70, IL-13, IL-17A, G-CSF, GM-CSF, IFN-γ, MIP-1α, MIP-
1β, RANTES, and Eotaxin. All procedures were carried out according to the manufacturer’s 
instructions. Samples were loaded in duplicates, and signal detection was done using the Luminex 
Bio-Plex 200 system.  
 
3.9 Statistical analyses:  
 
Statistical analysis was performed using GraphPad Prism software version 8 (San Diego, CA, 
USA). Quantitative results were expressed as mean and error bars represented standard deviation. 
Normal distribution of residuals was tested by histogram and Shapiro-Wilk test. The datasets which 
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were lognormal (as per the Shapiro-Wilk test), were subjected to logarithmic transformation, 
followed by two-way ANOVA (Analysis of Variance) with Dunnett’s multiple comparisons test. 
The critical value of α was set to 0.05 as a significant difference (two-tailed). 
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CHAPTER 4: RESULTS  
 
4.1 Effect of CD34 on the peripheral blood counts: 
 
Cell counts were performed on the blood samples using automatic cell counter to study if lack of 
CD34 had an effect on peripheral blood counts (Fig.4.1). Two-way ANOVA of total WBC show 
that interaction effect was significant (p=0.0349), while main effects were not significant. 
However, as shown in Fig.4.1, no difference was observed between WT and CD34 KO mice at any 
of the time-points.  Segmented neutrophils (SEG) in blood samples were also analyzed with two-
way ANOVA (Fig.4.2). Main effect of time-point post-LPS challenge was significant (p=0.0315), 
suggesting that intranasal LPS instillation induced a time-dependent response in the relative 
percentage of segmented neutrophils. Compared to CD34 KO at 0 h, CD34 KO at 15 h had a 3.5-
fold increase in the relative percentage of SEG (p=0.0268). In comparison to WT at 0 h, no 
statistically significant difference was observed at any of the time points (p>0.05). Also, no 
difference was observed at any of the time-points in the SEG relative percentage between WT and 
CD34 KO mice (Fig.4.2, p>0.05). Eosinophil relative percentage data was analyzed by using two-
way ANOVA (Fig.4.3.A). Main effect of time-point was significant (p<0.0001). Compared to 
CD34 KO at 0 h, CD34 KO at 3 h had a 1.9-fold decrease (p=0.0297), CD34 KO at 9 h had a 2.6-
fold decrease (p=0.0197), CD34 KO at 15 h had a 7.9-fold decrease (p=0.0002), and CD34 KO at 
24 h had a 10.5-fold decrease (p<0.0001). WT at 15 h had a 5.5-fold decrease (p=0.0212) and WT 
at 24 h had a 4.4-fold decrease (p=0.0112), compared to WT at 0 h. No difference was observed in 
the eosinophil relative percentage at any time-point for WT vs CD34 KO, p>0.05. As shown in 
Fig.4.3.B, for lymphocyte relative percentage in the blood samples, main effect of time-point was 
significant (p=0.0272). Indicating that the intranasal instillation of LPS induced time-dependent 
changes in the lymphocyte relative percentage in blood. Compared to CD34 KO at 0 h, CD34 KO 
at 15 h had a 2.5-fold decrease (p=0.0122) in the relative percentage of lymphocytes while there 
was no difference in WT. WT vs CD34 KO showed no difference at any of the time-points, p>0.05. 
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Lastly, platelet count data (Fig.4.4) in blood samples was evaluated using two-way ANOVA. 
Interaction effect was significant (p=0.0369); also both main effects, time and strain dependent, 
were significant. This indicates that the intranasal instillation of LPS induced a decrease in the 
number of platelets in peripheral blood at later time-points compared to baseline or 0 h. Significant 
interaction effect shows that the time-dependence is demonstrated by both WT and CD34 KO 
groups. Compared to WT at 0 h, WT at 3 h had a 1.9-fold decrease (p<0.0001), WT at 9 h had a 
1.4-fold decrease (p=0.0385), WT at 15 h had a 1.6-fold decrease (p=0.0137), and WT at 24 h also 
had a 1.6-fold decrease (p=0.0020). CD34 KO at 15 h had a 1.5-fold decrease (p=0.0125) and 
CD34 KO at 24 h also had a 1.5-fold decrease (p=0.0027), compared to CD34 KO at 0 h.  WT vs 
CD34 KO showed no difference at any of the time-points, p>0.05. 
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Fig.4.1:  WBC Counts in blood samples:   White blood cell counts in blood samples at various 
time points: 0-hour (no LPS; WT, N=3; CD34 KO, N=4), 3 h (WT, N=5; CD34 KO, N=4), 9 h 
(WT, N=3; CD34 KO, N=2), 15 h (WT, N=3; CD34 KO, N=3) and 24 h (WT, N=6; CD34 KO, 
N=6) post-LPS treatment with 50 µg LPS. The data is lognormal as per the Shapiro-Wilk test. 
Hence, logarithmic transformation was applied to the original data, followed by two-way ANOVA 
with Dunnett’s multiple comparisons test. Interaction effect was significant #, F (4,30) = 2.978, 
p=0.0349; main effect of time-point was non-significant, F (4, 30) = 2.638, p=0.0533; main effect 
of mouse strain was non-significant F (1, 30) = 0.1153, p=0.7366. WT vs CD34 KO, p>0.05 at all 
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Fig.4.2:  SEG Counts in blood samples:   Mature (segmented) neutrophil counts in blood samples 
at various time points: 0-hour (no LPS; WT, N=3; CD34 KO, N=4), 3 h (WT, N=5; CD34 KO, 
N=4), 9 h (WT, N=3; CD34 KO, N=3), 15 h (WT, N=3; CD34 KO, N=3) and 24 h (WT, N=6; 
CD34 KO, N=6) post-LPS treatment with 50 µg LPS. The data was analyzed by using two-way 
ANOVA with Dunnett’s multiple comparisons test.  Interaction effect was non-significant, F (4,30) 
= 1.055, p=0.3957; main effect of time-point was significant (*), F (4, 30) = 3.061, p=0.0315; 
main effect of mouse strain was non-significant F (1, 30) = 3.061, p=0.5846. WT vs CD34 KO, 





























             LYMPHOCYTE COUNTS BLOOD






























  34 
 
Fig.4.3.A, B:  Eosinophil and Lymphocyte Counts in blood samples:   (A) Eosinophil counts in 
blood samples at various time points: 0-hour (no LPS; WT, N=3; CD34 KO, N=4), 3 h (WT, N=5; 
CD34 KO, N=4), 9 h (WT, N=3; CD34 KO, N=2), 15 h (WT, N=3; CD34 KO, N=3) and 24 h 
(WT, N=6; CD34 KO, N=6) post-LPS treatment with 50 µg LPS. The data was analyzed by using 
two-way ANOVA with Dunnett’s multiple comparisons test. Interaction effect was non-
significant, F (4,30) = 0.7790, p=0.5477; main effect of time-point was significant (*), F (4, 30) = 
11.71, p<0.0001; and main effect of mouse strain was non-significant F (1, 19) = 1.796, p=0.1903. 
WT vs CD34 KO, p>0.05 at all time-points. (B) Lymphocyte counts in blood samples at various 
time points: 0-hour (no LPS; WT, N=3; CD34 KO, N=4), 3 h (WT, N=5; CD34 KO, N=4), 9 h 
(WT, N=3; CD34 KO, N=2), 15 h (WT, N=3; CD34 KO, N=3) and 24 h (WT, N=6; CD34 KO, 
N=6) post-LPS treatment with 50 µg LPS. The data was analyzed by using two-way ANOVA with 
Dunnett’s multiple comparisons test.  Interaction effect was non-significant, F (4,30) = 1.110, 
p=0.3702; main effect of time-point was significant (*), F (4, 30) = 3.181, p=0.0272; main effect 
of mouse strain was non-significant F (1, 30) = 0.2576, p=0.6155. WT vs CD34 KO, p>0.05 at all 
time-points. Results are expressed as mean ± SD. 
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Fig.4.4:  Platelet Counts in blood samples:   Platelet counts in blood samples at various time 
points: 0-hour (no LPS; WT, N=3; CD34 KO, N=4), 3 h (WT, N=5; CD34 KO, N=4), 9 h (WT, 
N=3; CD34 KO, N=2), 15 h (WT, N=3; CD34 KO, N=3) and 24 h (WT, N=6; CD34 KO, N=6) 
post-LPS treatment with 50 µg LPS. The data is lognormal as per the Shapiro-Wilk test. Hence, 
logarithmic transformation was applied to the original data, followed by two-way ANOVA with 
Dunnett’s multiple comparisons test. Interaction effect was significant (#), F (4, 30) = 2.934, 
p=0.0369; main effect of time-point was significant, F (4, 30) = 8.450, p=0.0001; main effect of 
mouse strain was also significant F (1, 30) = 4.725, p=0.0377. WT vs CD34 KO, p>0.05 at all 
time-points.  Results are expressed as mean ± SD. 
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4.2 Inflammatory cell migration into the lungs of CD34 knock-out mice and WT mice upon 
LPS challenge: 
 
To study the role of CD34 in acute lung inflammation, we used an LPS induced lung inflammation 
model of ALI. To study the development of lung inflammation, we first looked at the BAL cellular 
content.  BAL total leukocyte counts were subjected to a two-way analysis of variance having five 
time-points (0 no LPS, 3, 9, 15, and 24 h) and two mouse strains (WT and CD34 KO). As shown 
in 4.5, the main effect of time-point post-LPS challenge was significant (p<0.0001), indicating that 
intranasal LPS instillation induced time-dependent lung leukocyte recruitment, in both WT and 
CD34 KO mice. Dunnett’s multiple comparisons test revealed that there was no statistically 
significant difference between the total leukocyte counts at any of the post-LPS administration 
time-points in WT mice compared with CD34 knock-out mice (p>0.05).  
Next, we looked at the total macrophage counts in BAL (Fig.4.6.A). A two-way ANOVA revealed 
that both the main effects of time-point post-LPS challenge (p=0.0003), and mouse strain 
(p=0.0433), were significant. However, interaction effect was non-significant (p=0.1523). 
Thereby implying that the intranasal instillation of LPS induced time-dependent changes in 
alveolar macrophage numbers but no difference between WT mice and CD34 KO mice at any of 
the time-points post-LPS administration (p>0.05). In comparison to WT at 0 h, WT at 3 h 
experienced a 5.9-fold decrease (p=0.0008), WT at 9 h had a 5.1-fold decrease (p=0.0011) and 
WT at 15 h had a 6.3-fold decrease (p=.0066). While there was a 2.5-fold decrease in CD34 KO 
at 24 h compared with CD34 KO at 0 h (p=0.0261), no difference was observed for rest of the 
time-points.  
A two-way ANOVA of neutrophil numbers (Fig.4.6.B) revealed that there was no interaction effect 
(p=0.4445), but the main effect of time-point post-LPS challenge was significant (p = 0.0068), 
implying that intranasal LPS instillation induced time-dependent changes in neutrophil counts 
overall, but no difference between the number of neutrophils in the BAL fluid of WT mice and 
CD34 KO mice at any of the time-points post-LPS administration (Fig.4.6.B).  
Myeloperoxidase (MPO) estimation was performed to quantify the number of neutrophils trapped 
in the lung (Fig.4.7). The main effect of time-point post-LPS challenge was significant (p<0.0001). 
In comparison to WT at 0 h, WT at 3 h experienced an 11.9-fold increase (p=0.0001), WT at 9 h 
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had a 9.4-fold increase (p=0.0008) and WT at 15 h had an 8.8-fold increase (p=.0036). While there 
was no difference between CD34 KO at 0 h compared with CD34 KO at 3 h, CD34 KO at 9 h had 
an 8.5-fold increase (p=0.0021) and CD34 KO at 15 h had a 5.6-fold increase (p=0.0065). At 3-
hour post-LPS challenge, the MPO content was significantly higher in WT mice compared with 
CD34 knock-out mice (p=0.0308), but it was comparable in both groups for subsequent time 
points. Furthermore, immunofluorescence staining was performed with Gr-1 (red) which is a 
marker for polymorphonuclear leukocytes  and certain inflammatory monocytes/macrophages 
(Fig.4.8); vWF, which is a marker for endothelium and platelets, is stained green; and DAPI, which 
stains for cell nuclei, is blue. We observed intravascular (within green stained vessels) adherent 
Gr1 positive neutrophils (red colored polymorphonuclear cells), especially at 9 h in post-LPS 
exposed WT mice compared to CD34 KO mice. CD34 KO mice show a different pattern of Gr1 
positive cells, especially prevalent in alveolar septa (Fig.4.8). The alveolar staining for vWF 
(platelet aggregates) was not prominent in the CD34 KO mice at post-LPS exposure time-points, 
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Fig.4.5: BAL Leukocyte Counts:  Total Bronchoalveolar Lavage Fluid (BAL) leukocyte counts 
at 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, N=6), 9 h (WT, N=6; 
CD34 KO, N=5), 15 h (WT, N=3; CD34 KO, N=3) and 24 h (WT, N=6; CD34 KO, N=6) post-
LPS treatment with 50 µg LPS. Data analyzed using two-way ANOVA with Dunnett’s multiple 
comparisons test. Interaction effect was non-significant, F (4,45) = 1.293, p=0.2872; main effect 
of time-point was significant (****), F (4, 45) = 10.44, p<0.0001; main effect of mouse strain was 
not significant F (1, 45) = 1.890, p=0.1760. WT vs CD34 KO, p>0.05 for each time-point Results 
are expressed as mean ± SD.  
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Fig.4.6.A,B: Bronchoalveolar Lavage (BAL) Differential Cell Counts: (A) Alveolar 
macrophage numbers at 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, 
N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=3; CD34 KO, N=3) and 24 h (WT, N=6; 
CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Data analyzed using two-way ANOVA with 
Dunnett’s multiple comparisons test. Interaction effect was non-significant, F (4,44) = 1.769, 
p=0.1523; main effect of time-point was significant (***), F (4, 44) = 6.709, p=0.0003; main effect 
of mouse strain was significant (°) F (1, 44) = 4.331, p=0.0433. WT vs CD34 KO, p>0.05 for each 
time-point (B) Neutrophil numbers at 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; 
CD34 KO, N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=3; CD34 KO, N=3) and 24 h 
(WT, N=6; CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Data analyzed using two-way 
ANOVA with Dunnett’s multiple comparisons. Interaction effect was non-significant, F (4,38) = 
0.954, p=0.4445; main effect of time-point was significant (**), F (4, 38) = 4.167, p = 0.0068; 
main effect of mouse strain was not significant F (1, 38) = 0.0030, p=0.9562. WT vs CD34 KO, 
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Fig.4.7: Myeloperoxidase estimation in mouse lungs: MPO amount per gram protein at various 
time points: 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, N=6), 9 h 
(WT, N=6; CD34 KO, N=5), 15 h (WT, N=6; CD34 KO, N=6) and 24 h (WT, N=2; CD34 KO, 
N=3) post-LPS treatment with 50 µg LPS. The data is lognormal as per the Shapiro-Wilk test. 
Hence, logarithmic transformation was applied to the original data, followed by two-way ANOVA 
with Dunnett’s multiple comparisons test. Interaction effect was non-significant, F (4,44) = 1.601, 
p=0.1910; main effect of time-point was significant (****), F (4, 44) = 9.982, p<0.0001; main 
effect of mouse strain was not significant F (1, 44) = 1.134, p=0.2927. WT vs CD34 KO at 3 h, 







Fig.4.8: Immunofluorescence staining in mouse lung sections: Immunofluorescence staining on 
mouse lungs was performed for various time points: 0 (no LPS), 9 and 24h in WT (WT, N=2) and 
CD34 KO (N=2) mice exposed to 50 µg LPS. Red: Gr-1, marker for polymorphonuclear cells or 
neutrophil granulocytes; Green: vWF, marker for endothelium and platelets; Blue: DAPI, staining 
for cell nucleus. Representative images from three independent experiments. Note the presence of 
intravascular Gr1 positive (red colored) polymorphonuclear cell (neutrophils) marked with yellow 
arrows in WT mice at 9 h post-LPS exposure time-point. CD34 KO mice show a different pattern 
of Gr1 positive cells, especially prevalent in alveolar septa. Platelet aggregates  can be seen (white 
arrows) as vWF positive (green stained) clusters in alveolar septal post-LPS exposure. B: 






4.3 CD34 knock-out mice show altered lung pathology upon LPS challenge compared with 
the WT mice:  
 
Total protein concentration in BAL samples was quantified as a surrogate marker for pulmonary 
vascular permeability. Two-way ANOVA analysis indicated that main effects of time-point post-
LPS challenge (p<0.0001) and mouse strain (p=0.0017) were significant. Thereby implying that 
the intranasal instillation of LPS induced time-dependent changes in pulmonary vascular 
permeability. In comparison to WT at 0 h, WT at 3 h experienced a 4-fold increase (p=0.0006), 
WT at 9 h had a 3.4-fold increase (p=0.0050) WT at 15 h had a 5.5-fold increase (p<0.0001), and 
WT at 24 h showed a 3.1-fold increase (p=0.0026). While there was a 3-fold increase in CD34 KO 
at 15 h compared with CD34 KO at 0 h (p=0.0065), no difference was observed for rest of the 
time-points. As shown in Fig.4.9, WT mice have a higher total protein content in the BAL 
supernatant at 3-hour post-LPS administration compared to the CD34 knock-out mice (p=0.0452).  
The difference in BAL total protein amounts between the two groups was seen at 24 h time-point 
as well (p=0.0113), pointing towards an attenuated vascular permeability in the CD34 knock-out 
compared to WT mice in response to LPS. 
 H & E staining was performed on the lung samples from time points 0, 3, 9, 15 and 24 hours. 
Lungs were congested, and perivascular space was infiltrated with leukocytes as shown at 3 h in 
WT mice compared to CD34 KO mice (Fig.4.10).  At 9, 15 and 24 h post-LPS administration, 
lungs in the WT mice were congested and perivascular space was infiltrated with leukocytes 
compared with the CD34 knock-out mice (Fig.4.11). Note at 24 h, there are leukocytes adhering to 
the large blood vessel (BV) despite perfusion of lungs; alveolar infiltration near a bronchus (B) is 
significant in both strains showing dissemination of inflammation. Semi-quantitative scoring of 
lung inflammation was also performed on H & E stained lung sections (Fig.4.12). Two-way 
ANOVA with Dunnett’s multiple comparisons test showed that for perivascular inflammation 
score, the main effects of time-point (p<0.0001) and mouse strain (p=0.0030) were significant.  
For peribronchiolar inflammation score, the main effects of time-point (p<0.0001) and mouse 
strain were (p=0.0050). For Septal inflammation score, the main effects of time-point (p<0.0001) 
and mouse strain (p=0.0009) were significant. This indicates that LPS induced time-dependent 
changes in perivascular, peribronchiolar, and septal inflammation in both groups. No difference 
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between WT and CD34 KO groups was observed in perivascular, peribronchiolar, and septal 
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Fig.4.9: BAL Total Protein (μg) estimation assay:  Total protein estimation in the BAL samples 
at various time points: 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, 
N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=6; CD34 KO, N=6) and 24 h (WT, N=6; 
CD34 KO, N=6) post-LPS treatment with 50 µg LPS. The data is lognormal as per the Shapiro-
Wilk test. Hence, logarithmic transformation was applied to the original data, followed by two-
way ANOVA with Dunnett’s multiple comparisons test. Interaction effect was non-significant, F 
(4,51) = 2.436, p=0.0589; main effect of time-point was significant (****), F (4, 51) = 9.404, 
p<0.0001; main effect of mouse strain was significant (°°) F (1,51) = 10.95, p=0.0017. WT vs 
CD34 KO at 3 h (p=0.0452), at 24 h (p=0.0113). Experiment was performed in duplicates. All 





Fig.4.10: Lung H&E Histology (0, 3 h): Representative images from H&E stained perfused left 
lung from 0-hour (no LPS; WT, N=7; CD34 KO, N=7), and 3 h (WT, N=6; CD34 KO, N=6) post-







Fig.4.11: Lung H&E Histology (0, 9, 15, 24 h): Representative images from H&E stained 
perfused left lung from 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 9 h (WT, N=6; CD34 KO, 
N=5), 15 h (WT, N=3; CD34 KO, N=4) and 24 h (WT, N=6; CD34 KO, N=6) post-LPS treatment 
with 50 µg LPS. Note at 24 h, there are leukocytes adhering to the large blood vessel (BV) despite 
perfusion of lungs; alveolar infiltration near a bronchus (B) is significant in both strains showing 
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Fig.4.12: Histological Scoring of Inflammation in lung sections: Perivascular, peribronchiolar 
and septal inflammation scores from H&E stained left lung from 0-hour (no LPS; WT, N=7; CD34 
KO, N=7), 3 h (WT, N=6; CD34 KO, N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=3; 
CD34 KO, N=4) and 24 h (WT, N=6; CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Two-
way ANOVA with Dunnett’s multiple comparisons test was used to analyze the data. For 
perivascular inflammation score, interaction effect was non-significant, F (4,46) = 2.438, 
p=0.0603; main effect of time-point was significant (****), F (4, 46) = 47.80, p<0.0001; main 
effect of mouse strain was significant (°°) F (1,46) = 9.805, p=0.0030.  For peribronchiolar 
inflammation score, interaction effect was non-significant, F (4,46) = 1.155, p=0.3430; main effect 
of time-point was significant (****), F (4, 46) = 55.25, p<0.0001; main effect of mouse strain was 
significant (°°) F (1,46) = 8.700, p=0.0050. For Septal inflammation score, interaction effect was 
non-significant, F (4,51) = 1.322, p=0.2743; main effect of time-point was significant (****), F 
(4, 51) = 73.57, p<0.0001; main effect of mouse strain was significant (°°°) F (1,51) = 12.52, 
p=0.0009. No difference in perivascular, peribronchiolar, and septal inflammation score in WT vs 














4.4 CD34 knock-out mice show reduced expression of TNF-α, IL-1β, KC, IL-6, IL-10, and 
MIP-1α upon LPS challenge compared with the WT mice: 
 
We looked at the level of various cytokines and chemokines associated with ALI in BAL fluid to 
study the inflammatory response induced by LPS.  The 2-way ANOVA interaction effect between 
time-point and mouse strain was significant in TNF-α (p<0.0001), IL-1β (p=0.0235), KC 
(p<0.0001), IL-6 (p=0.0197)  (Fig.4.13.A, B, C, and D, respectively). This indicates that the 
intranasal instillation of LPS induced time-dependent change in the levels of TNF-α, IL-1β, KC, 
and IL-6 in both WT and CD34 KO groups. LPS induces early (3 h) release of BAL TNF-α, IL-
1β, KC, and IL-6 in WT mice when compared to no LPS at baseline (0 h) or later time-points at 9, 
15 and 24 h (Fig.4.13.A, B, C, and D). WT mice show increased expression of pro-inflammatory 
cytokines, TNF-α (p<0.0001), IL-1β (p=0.0008), KC (p<0.0001) and IL-6 (p=0.0004), in BAL 
supernatant 3-hour post-LPS administration compared with the CD34 knock-out mice (Fig.4.13.A, 
B, C, and D). Two-way ANOVA on IL-10 (p=0.0423) and MIP-1α (p=0.0066) data shows that 
significant interaction effect between time-points and strain (Fig.4.14.A, B). This indicates that the 
intranasal instillation of LPS induced time-dependent change in the levels of IL-10 and MIP-1α in 
both WT and CD34 KO groups. LPS induces early (3 h) release of BAL IL-10 and MIP-1α in WT 
mice when compared to no LPS at baseline (0 h) or later time-points at 9, 15 and 24 h (Fig.4.14.A, 
B). Fig.4.14.A shows higher expression of anti-inflammatory cytokine IL-10 in WT mice at 3-hour 
post-LPS challenge, compared to CD34 knock-out mice (p=0.0017). As shown in Fig.4.14.B, MIP-
1α is upregulated in WT group compared to CD34 knock-out group, 3-hour after LPS 
administration (p<0.0001). Two-way ANOVA on IL-12(p40) (Fig.4.15) shows that the main 
effects of time-point (p=0.0018) and mouse strain (p=0.0010) were significant. This indicates a 
time-dependent effect of LPS on IL-12(p40) levels in BAL in both WT and CD34 KO groups. 
However, no difference was observed between WT and CD34 KO groups at any of the time-points 
(p>0.05). Two-way ANOVA on IFN-γ (Fig.4.16.A) shows that the interaction effect not 
significant. Two-way ANOVA on G-CSF (Fig.4.16.B) both the main effects of time-point 
(p=0.0008), and mouse strain (p=0.0010.) were significant. But no difference was observed at any 
of the time-points in the expression levels of IFN-γ (Fig.4.16.A) and G-CSF (Fig.4.16.B) in BAL 
samples between the two groups. Two-way ANOVA on MIP-1b (Fig.4.17.A) shows that 
interaction effect (p=0.0034), and the main effect of time-point was significant as well (p=0.0013). 
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This indicates that the intranasal instillation of LPS induced time-dependent change in the levels 
of MIP-1b in both WT and CD34 KO groups. At 3 h post-LPS challenge, WT had a higher level 
of MIP-1b compared with CD34 KO (p<0.0001). Two-way ANOVA on MCP-1 (Fig.4.17.B) 
indicates that the main effect of time-point was significant (p=0.0019). There was no difference in 
MCP-1 levels in BAL between WT and CD34 KO at any of the time-points (p>0.05). Two-way 
ANOVA on RANTES (Fig.4.18) shows that the main effect of time-point was significant 
(p=0.0090), indicating LPS induced time-dependent change in the levels of RANTES. Compared 
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Fig.4.13.A, B, C, D: TNF-α, IL-1β, KC and IL-6 content in BAL fluid: TNF-α, IL-1β, KC and 
IL-6 in the BAL samples at various time points: 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h 
(WT, N=6; CD34 KO, N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=7; CD34 KO, N=6) 
and 24 h (WT, N=6; CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Data sets were analyzed 
using two-way ANOVA with Dunnett’s multiple comparisons test. (A) TNF-α: Interaction effect 
was significant (####), F (4,51) = 9.028, p<0.0001; main effect of time-point was significant, F 
(4, 51) = 11.13, p<0.0001; main effect of mouse strain was significant F (1, 51) = 10.92, p=0.0017. 
WT vs CD34 KO at 3 h, p<0.0001; (B) IL-1β: Interaction effect was significant (#), F (4, 52) = 
3.087, p=0.0235; main effect of time-point was significant, F (4, 52) = 6.353, p=0.0003; main 
effect of mouse strain was significant F (1, 52) = 9.111, p=0.0039. WT vs CD34 KO at 3 h, 
p=0.0008; (C) KC: Interaction effect was significant (####), F (4, 52) = 7.554, p<0.0001; main 
effect of time-point was significant, F (4, 52) = 16.01, p<0.0001; main effect of mouse strain was 
significant F (1, 52) = 15.01, p=0.003. WT vs CD34 KO at 3 h, p<0.0001; (D) IL-6: Interaction 
effect was significant (#), F (4, 52) = 3.213, p=0.0197; main effect of time-point was significant, 
F (4, 52) = 7.818, p<0.0001; main effect of mouse strain was significant F (1, 52) = 10.72, 
p=0.0019. WT vs CD34 KO at 3 h, p=0.0004.  Results are expressed as mean ± SD. Experiment 
was performed in duplicates. 
56 
 
                                                                           





             IL-10 in BAL fluid





















             MIP-1α in BAL fluid



















Fig.4.14.A, B: IL-10 and MIP-1α content in BAL fluid: IL-10 and MIP-1α in the BAL 
samples at various time points: 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; 
CD34 KO, N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=7; CD34 KO, N=6) and 
24 h (WT, N=6; CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Data sets were 
analyzed using two-way ANOVA with Dunnett’s multiple comparisons test. (A) IL-10: 
Interaction effect was significant (#), F (4, 52) = 2.669, p=0.0423; main effect of time-point 
was significant, F (4, 52) = 8.844, p<0.0001; main effect of mouse strain was significant F 
(1, 52) = 7.529, p=0.0083. WT vs CD34 KO at 3 h, p=0.0017. (B) MIP-1α: Interaction 
effect was significant (##), F (4, 53) = 3.995, p=0.0066; main effect of time-point was 
significant, F (4, 53) = 13.18, p<0.0001; main effect of mouse strain was significant F (1, 
53) = 10.44, p=0.0021. WT vs CD34 KO at 3 h, p<0.0001.  Results are expressed as mean 
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Fig.4.15: IL-12(p40) content in BAL fluid: IL-12(p40) in the BAL samples at various time points: 
0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, N=6), 9 h (WT, N=6; 
CD34 KO, N=5), 15 h (WT, N=7; CD34 KO, N=6) and 24 h (WT, N=6; CD34 KO, N=6) post-
LPS treatment with 50 µg LPS. Data sets were analyzed using two-way ANOVA with Dunnett’s 
multiple comparisons test. Interaction effect was non-significant, F (4, 52) = 1.188, p=0.3271; 
main effect of time-point was significant (**), F (4, 52) = 4.977, p=0.0018; main effect of mouse 
strain was significant (°°) F (1, 52) = 12.27, p=0.0010. WT vs CD34 KO, p>0.05 at all time-points. 
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Fig.4.16.A, B: IFN-γ and G-CSF content in BAL fluid: IFN-γ and G-CSF in the BAL samples 
at various time points: 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, 
N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=7; CD34 KO, N=6) and 24 h (WT, N=6; 
CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Data sets were analyzed using two-way 
ANOVA with Dunnett’s multiple comparisons test. (A) IFN-γ: Interaction effect was non-
significant, F (4, 51) = 1.023, p=0.4043; main effect of time-point was non-significant, F (4, 51) 
= 1.308, p=0.2797; main effect of mouse strain was non-significant F (1, 51) = 2.055, p=0.1578. 
WT vs CD34 KO, p>0.05 at all time-points. (B) G-CSF: Interaction effect was non-significant, F 
(4, 52) = 0.7037, p=0.5930; main effect of time-point was significant (***), F (4, 52) = 5.597, 
p=0.0008; main effect of mouse strain was significant (°) F (1, 52) = 4.911, p=0.0311. WT vs 
CD34 KO, p>0.05 at all time-points. All results are expressed as mean ± SD. Experiment was 
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Fig.4.17.A, B: MIP-1b and MCP-1 content in BAL fluid: MIP-1b and MCP-1 in the BAL 
samples at various time points: 0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 
KO, N=6), 9 h (WT, N=6; CD34 KO, N=5), 15 h (WT, N=7; CD34 KO, N=6) and 24 h (WT, N=6; 
CD34 KO, N=6) post-LPS treatment with 50 µg LPS. Data sets were analyzed using two-way 
ANOVA with Dunnett’s multiple comparisons test. (A) MIP-1b: Interaction effect was significant 
(##), F (4, 53) = 4.477, p=0.0034; main effect of time-point was significant, F (4, 53) = 5.283, 
p=0.0013; main effect of mouse strain was significant F (1, 53) = 5.959, p=0.0180. WT vs CD34 
KO at 3 h, p<0.0001; (B) MCP-1: Interaction effect was non-significant, F (4, 52) = 0.9960, 
p=0.4181; main effect of time-point was significant (**), F (4, 52) = 4.931, p=0.0019; main effect 
of mouse strain was non-significant F (1, 52) = 1.556, p=0.2178. WT vs CD34 KO, p>0.05 at all 
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Fig.4.18: RANTES content in BAL fluid: RANTES in the BAL samples at various time points: 
0-hour (no LPS; WT, N=7; CD34 KO, N=7), 3 h (WT, N=6; CD34 KO, N=6), 9 h (WT, N=6; 
CD34 KO, N=5), 15 h (WT, N=7; CD34 KO, N=6) and 24 h (WT, N=6; CD34 KO, N=6) post-
LPS treatment with 50 µg LPS. Data set was analyzed using two-way ANOVA with Dunnett’s 
multiple comparisons test. Interaction effect was non-significant, F (4, 53) = 1.236, p=0.2874; 
main effect of time-point was significant (**), F (4, 53) = 3.773, p=0.0090; main effect of mouse 
strain was non-significant F (1, 53) = 3.254, p=0.0769. WT vs CD34 KO at 15 h, p=0.0403. All 
results are expressed as mean ± SD. Experiment was performed in duplicates. 
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CHAPTER 5: DISCUSSION 
 
In this study, we have used a mouse model with 12- to 16-wk-old mice and administered intranasal 
LPS (50 µL/mice) from Escherichia coli O55:B5 (diluted in sterile saline at 1 g/L). This LPS model 
shows neutrophilic inflammation response as well as increase in intrapulmonary cytokines which 
are similar to ARDS (Matute-Bello, 2008 ). While CD34 KO mice have been utilized previously 
in studying various inflammatory conditions as well as in one study of ALI in a bleomycin model 
(Lo et al., 2017), our project is novel in terms of studying LPS induced pattern recognition receptor, 
TLR4 mediated acute lung injury in CD34 KO mice.  
Our results show that intranasal LPS challenge induced time-dependent changes in both groups in 
the total WBC counts in peripheral blood, relative percentages of mature/segmented neutrophil, 
eosinophil, lymphocyte, and platelet counts in peripheral blood samples from mice. Similarly, LPS 
induced changes across different time-points in BAL total leukocyte counts, alveolar macrophage 
counts, neutrophil counts, MPO activity, BAL total protein content. TNF-α, IL-1β, KC, IL-6, IL-
10, MIP-1a, and MIP-1b levels in BAL demonstrated post-LPS time-dependent changes in both 
the strains. IL-12(p40), MCP-1, G-CSF and RANTES levels demonstrated post-LPS time-
dependent behaviour as well.  
Acute LPS exposure induces mobilization of leukocytes from storage sites like the bone marrow 
and spleen. Our results show no difference between WT and CD34 KO mice total white blood cell 
counts. Compared to CD34 KO at 0 h, CD34 KO at 15 h had a 3.5-fold increase in the relative 
percentage of SEG, but it was not observed in WT mice. Blood eosinophil counts dropped from 
baseline (0 h) in CD34 KO group, starting at 3 h with 1.9-fold drop up to 10.9-fold drop at 24 h.  
Blood eosinophil counts dropped from baseline (0 h) in WT group, 5.5-fold at 15 h and 4.4-fold at 
24 h.  Further, compared to CD34 KO at 0 h, CD34 KO at 15 h had a 2.5-fold decrease in the 
relative percentage of lymphocytes while there was no difference in WT. Lastly, platelet counts 
decreased in both WT and CD34 KO groups for subsequent time-points, compared to baseline (0 
h) of respective groups. WT at 15 h had a 1.6-fold decrease, and WT at 24 h also had a 1.6-fold 
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decrease, compared to WT at 0 h. CD34 KO at 15 h had a 1.5-fold decrease and CD34 KO at 24 h 
also had a 1.5-fold decrease, compared to CD34 KO at 0 h. This drop in platelet counts could be 
due to the migration of platelets in lung vasculature, where platelets can form P-selectin dependent 
aggregates with neutrophils (Zarbock et al., 2006). Due to coagulation of a number of blood 
samples immediately after cardiac puncture, the sample sizes at different time-points were reduced. 
There was no difference observed between the two groups at different time-points, most likely due 
to reduced sample size for multiple time points.  
Our results showed no statistically significant difference between the total leukocyte counts at any 
of the post-LPS administration time-points in WT mice compared with CD34 KO mice. This is a 
similar result to the bleomycin model study (Lo et al., 2017). Similarly, no difference was observed 
in the alveolar macrophage counts between WT and CD34 KO group at any of the post-LPS 
administration time-points. However, in WT group, compared to baseline (WT, 0 h) the alveolar 
macrophage counts dropped 5.9-fold at 3 h, 5.1-fold at 9 h and 6.3-fold at 15 h. In contrast, in 
CD34 KO group, alveolar macrophage counts dropped 2.5-fold at 24 h, compared to baseline 
(CD34 KO, 0 h). The drop could be because of more adherent macrophage post-LPS instillation 
not washing away during BAL. Another possible reason could be the apoptosis of macrophage 
after phagocytosis. No difference was observed in the neutrophil counts between WT and CD34 
KO group at any of the post-LPS administration time-points. The reason behind lack of neutrophils 
in BAL of WT at 3-hour time-point compared to no LPS WT group could be due to either spurious 
counts or the effect of including both male and female mice in the study. 
In this study, I had used both male and female mice due to lack of knowledge between the gender 
differences in lung disease. But for each group, I tried to keep the male to female ratio as close to 
1 as possible within the constraints of experimental animal numbers. While there have been studies 
showing a difference in inflammatory response between male and female mice, the exact response 
varies depending on the model used (Card et al., 2006). Card et al. showed that males had 
significantly severe hypothermia and greater airway hyperresponsiveness than females post-
intratracheal LPS administration, as well as higher BALF total cells, neutrophils, and TNF-α levels 
6 h post-LPS challenge. We looked at the data in order to understand if the gender difference might 
be responsible in our study for not achieving significant results, however there was no clear pattern 
based on gender, with both the genders contributing to outliers. This can be attributed to the low 
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number of animals from each gender (N=1-3 per group for each gender, for each time-point), and 
thus the inability to statistically analyse the data based on gender.  
The number of leukocytes in the BAL samples account for the cells that had migrated into the 
alveoli of the mice upon LPS-administration and subsequently washed off with bronchoalveolar 
lavage procedure. However, most neutrophils get trapped in the vasculature or interstitial space of 
inflamed lungs (Reutershan et al., 2005). Lung MPO in our experimental design, is thus an 
indicator of the number of adherent neutrophils left in the lung after lavage and vascular lung 
perfusion. Interestingly, our results show that the lung MPO content was significantly higher at 3-
hour time-point in WT mice compared with CD34 knock-out mice. CD34 KO mice showed a 
delayed rise in MPO, starting at 9 h. Furthermore, immunofluorescence staining results show 
prominent alveolar staining with Gr-1, a marker for polymorphonuclear leukocytes and a subset of 
inflammatory monocytes/macrophages. We also noted a lower vWF alveolar septal expression in 
CD34 KO mice post-LPS exposure, which points to a plausible suppression of LPS induced platelet 
activation in CD34 KO mice. Platelet activation is essential for heterotypic leukocyte adherence to 
pulmonary capillaries (Ma et al., 2008). I did not quantify the regional lung Gr1 and vWF 
expression from confocal microscopy, but quantification might help support the lung MPO and 
BAL protein data where CD34 KO mice have significantly lower MPO levels at 3 h time-point 
compared to WT mice.  
Our immunofluorescence results show presence of CD34 in the bronchiolar epithelium, in addition 
to alveolar septa, in WT mice at 0 h (No LPS).To my knowledge, these observations are reported 
for the first time in the lung tissues with the use of a novel antibody, EP373Y, which is reactive to 
the conserved C-terminal sequence of human CD34 protein. The same antibody also detected CD34 
in the lung tissues of dogs and pigs (Appendix B, Fig.B.1, Fig.B.3), showing expression of CD34 
on bronchiolar epithelia as well as alveolar septa. Our observations of CD34 expression in the 
bronchiolar epithelium and given the pan-selectin affinity of CD34 (Felschow et al., 2001; Alfaro 
et al., 2011; Ohnishi et al., 2013; AbuSamra et al., 2017), reinforce a plausible role of CD34 in 
lung neutrophil adherence as indicated by higher lung MPO as well as BAL neutrophils in LPS 
exposed WT mice when compared to CD34 KO, whereby CD34 might be facilitating the 
interaction between lung epithelium and neutrophils. 
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WT mice also had a significantly higher total protein content in the BAL supernatant at 3-hour 
post-LPS administration compared to the CD34 KO mice, which shows that WT mice had 
increased vascular permeability. The significant difference in BAL total protein amounts between 
the two groups was seen at 24 h time-point as well, pointing towards vascular barrier protection as 
indicated by attenuated vascular permeability in the CD34 KO mice. Thus, CD34 KO mice display 
delays in lung neutrophil recruitment kinetics (lung MPO content) and loss of lung vascular barrier 
properties (BAL total protein content).  
Cytokine expression levels were studied using 23-plex ELISA in order to characterize the lung 
inflammatory response in our model. WT mice showed increased expression of pro-inflammatory 
cytokines, TNF-α and IL-1β  in BAL supernatant 3-hour post-LPS administration compared with 
the CD34 knock-out mice. Our results are similar to previous study, where TNF-α levels begin to 
rise as early as 30 min post intratracheal LPS challenge and peak at 1 h in WT rats, the levels 
remain high for up to 4 h (Xing et al., 1994; Li et al., 1998). Mice do not express IL-8 but they 
have KC chemokine, which is a mouse homologue of human IL-8. IL-8 is induced by pro-
inflammatory cytokines TNF-α, IL-6, IFN-γ and IL-1β, and acts as a neutrophil chemoattractant 
(Brat et al., 2005; Matute-Bello, 2008 ). KC expression was also elevated in WT mice at 3-hour 
post-LPS challenge, compared to CD34 knock-out mice. IL-6 activates leukocytes, and IL-6 levels 
correlate with severity of ARDS (Stapleton et al., 2019). IL-6 expression was 5-fold higher in WT 
mice at 3-hour post-LPS challenge, compared to CD34 knock-out mice.  IL-6 levels in rats have 
been shown to peak within 6 h post-intratracheal LPS challenge and it was not detected in BAL 
until an hour post-LPS challenge (Xing et al., 1994). There was higher expression of anti-
inflammatory cytokine IL-10 in WT mice at 3-hour post-LPS challenge, compared to CD34 knock-
out mice. IL-10 has been associated with high mortality rate in ARDS (Stapleton et al., 2019). MIP-
1α is a pro-inflammatory chemokine which plays a role in neutrophil chemotaxis in mice (Gao et 
al., 1997). MIP-1α is upregulated in WT group compared to CD34 knock-out group, 3-hour after 
LPS administration. IL-12 p40 subunit of IL-12 is secreted early on by the antigen-presenting cells 
like macrophages, when they interact with PAMPs (Abdi, 2002). IL-12 p40 levels in BALF had no 
difference between WT and CD34 KO at any of the time-points. G-CSF is a principal cytokine 
involved in the proliferation, differentiation and mobilization of neutrophilic granulocytes 
(Panopoulos et al., 2008). RANTES is actively involved in recruitment of leukocytes such as 
macrophages, basophils, and eosinophils to the site of inflammation (Aldinucci et al., 2014). No 
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difference was observed in the expression levels of IFN-γ, G-CSF and RANTES in BAL samples 
between the two groups. LPS induces innate immune (TLR4) mediated NF-κB activation, IL-1β 
inflammasome activation as well as cell-death induced cytokine/chemokine responses (Takeda et 
al., 2004). WT mice released peak cytokines and chemokines such as, TNF-α, IL-1β, KC, MIP-1α, 
IL-6, IL-10 and IL-12 p40 sub-unit, at 3 h post-LPS exposure when compared to no LPS (0 h), 
which is in-line with previous reports (Bosmann et al., 2012). CD34 KO mice released negligible 
TNF-α and IL-12 p40 sub-unit. Moreover, there was negligible LPS induced IL-1β or IL-10 release 
in CD34 KO mice. These results indicate that CD34 KO mice potentially lack in TLR4 mediated 
IL-1β inflammasome activation when compared to WT mice. LPS induced an early (3 h) and a 
later (15 h) peak in IL-6 concentrations in WT mice compared to 5-fold lower concentrations in 
CD34 KO mice (at 3 h). 
Collectively, the lung histology, MPO, BAL protein content and BAL cytokine/chemokine analysis 
indicate that CD34 KO mice show delays in lung vascular permeability and neutrophil adhesion 
kinetics and a suppression of IL-1β and TNFα dependent innate immune response. Our results 
propose novel role of CD34 in neutrophil adherence as well as activation and corroborate with the 
recent in vivo studies showing L-selectin mediated neutrophil adherence, activation as well as 
clearance from the inflammation site (McEver, 2015; Liu et al., 2017).  I have summarized the 
effects of LPS on mouse lungs and possible roles of CD34 in neutrophil adherence, and activation, 
as well as in TLR4 mediated inflammasome activation in Fig.5.1. This figure was adopted from a 
doctoral thesis (Zhao, 2009). 
As our study was designed to understand the early phase of immune activation, it will be interesting 
to study the later time-points as innate immune activation precedes the repair or immune cell 
clearance pathways, which in the intranasal LPS model can last up to a few weeks. It is quite 




















Fig.5.1 Role of CD34 in LPS-induced acute lung injury in mice: TLR4 on alveolar macrophages 
(AM) can bind to LPS which leads to activation of AM via TLR4 signaling. Activated AMs and 
epithelial cells release early pro-inflammatory cytokines, TNF-α and IL-1β. Both lead to expression 
of IL-6 and KC, which is a functional homologue of human IL-8 in mouse. KC is an essential 
chemotactic factor and plays a role in the development of ALI. Chemokines activate β2 integrin 
and L-selectin expression which play an important role in neutrophil migration across the 
endothelia and activation of PMNs by IL-6 leads to increased vascular damage because of 
degranulation of activated PMNs, releasing toxic chemicals like ROS, and proteinases. Our results 
suggest that CD34 might be involved in: 1) L-selectin mediated neutrophil adherence, activation 
as well as clearance from the site of inflammation, since CD34 KO mice display delays in lung 
neutrophil recruitment kinetics (lung MPO content) and delays in loss of lung vascular barrier 
properties (BAL total protein content), 2) IL-1β and TNFα dependent innate immune response, 
since CD34 KO mice display impaired production of ALI associated cytokines and chemokines, 
TNF-α, IL-1β, KC, MIP-1α, IL-6, IL-10 and IL-12 p40 sub-unit, compared to their levels in BAL 
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CHAPTER 6: CONCLUSION AND FUTURE DIRECTIONS 
 
The objective of this project was to study the intranasal LPS induced inflammatory response in 
the lungs of CD34 knock-out mice compared with WT (C57BL/6N) mice. To that end, we carried 
out experiments at different time-points post LPS challenge, to look at several factors associated 
with an inflammatory response in the lungs of mice, including peripheral blood cell counts, total 
and differential leukocyte cell counts in BALF, adherent neutrophils left in the lung after lavage 
(MPO levels, Gr-1 IF staining), lung vascular permeability (BAL total protein), inflammation 
scoring (H&E staining), and cytokine and chemokine levels in BALF. 
 
Our results demonstrate a time-dependent inflammatory response in WT mice and CD34 knock-
out mice in response to intranasal LPS challenge. While there was no difference in the total or 
differential leukocyte counts, including, alveolar macrophages and neutrophils, lung MPO 
content in CD34 KO was lower than WT group at 3 h time-point. Additionally, CD34 KO mice 
MPO levels begin to rise at 9 h, as opposed to early 3 h rise in WT mice. Suggesting that CD34 
KO mice display delays in lung neutrophil recruitment kinetics. In addition, immunofluorescence 
staining images show distinct alveolar staining with Gr-1, a marker for polymorphonuclear 
leukocytes and a subset of inflammatory monocytes/macrophages. Our immunofluorescence 
staining image in WT mice at 0 h (No LPS) also show presence of CD34 in the bronchiolar 
epithelium, in addition to alveolar septa. Our observations of CD34 expression in the bronchiolar 
epithelium and given the pan-selectin affinity of CD34 (Felschow et al., 2001; Alfaro et al., 2011; 
Ohnishi et al., 2013; AbuSamra et al., 2017), reinforce a plausible role of CD34 in lung neutrophil 
adherence as indicated by higher lung MPO in LPS exposed WT mice when compared to CD34 
KO. CD34 KO mice display loss of lung vascular barrier properties as suggested by lower total 
protein in BAL supernatant in CD34 KO mice at 3 h and 24 h time-points.  
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LPS induces innate immune (TLR4) mediated NF-κB activation, IL-1β inflammasome activation 
as well as cell-death induced cytokine/chemokine responses (Takeda et al., 2004). In WT mice 
cytokines and chemokines such as, TNF-α, IL-1β, KC, MIP-1α, IL-6, IL-10 and IL-12 p40 sub-
unit, peaked at 3 h, which is in-line with previous reports (Bosmann et al., 2012). While CD34 
KO mice released negligible TNF-α, IL-1β, IL-10 and IL-12 p40 sub-unit. These results indicate 
that CD34 KO mice potentially lack in TLR4 mediated IL-1β inflammasome activation when 
compared to WT mice.  
 
Together, the lung histology, MPO, BAL protein content and BAL cytokine/chemokine analysis 
suggest that CD34 KO mice show delayed lung vascular permeability and neutrophil adhesion 
kinetics, and a suppression of IL-1β and TNFα dependent innate immune response. Our study 
was designed to understand the early phase of immune activation, lasting up to 24 h. Future 
experiments can be conducted to study the later time-points as innate immune activation precedes 
the repair or immune cell clearance pathways, which in the intranasal LPS model can last up to a 
few weeks. It is quite probable that the CD34 KO mice will show defective repair or lung 
leukocyte clearance due to impaired immune system activation. 
 
Further, quantification of the regional lung Gr1 and vWF expression from confocal microscopy, 
might help support the lung MPO and BAL protein data where CD34 KO mice have significantly 
lower MPO levels at 3 h time-point compared to WT mice.  
 
One of the limitations of this study is that both male and female mice were used due to lack of 
knowledge between the gender differences in lung disease. While there have been studies 
showing a difference in inflammatory response between male and female mice, the exact response 
varies depending on the model used (Card et al., 2006). Card et al. showed that males had 
significantly severe hypothermia and greater airway hyperresponsiveness than females post-
intratracheal LPS administration, as well as higher BALF total cells, neutrophils, and TNF-α 
levels 6 h post-LPS challenge. Future studies can be conducted with either a larger sample size 
to include equal number of male and female in each group or conducting experiments with 




While intranasal LPS mouse model of ALI provides the advantage of reproducibility, with some 
similarities to human ARDS symptoms, especially with respect to increase in intrapulmonary 
cytokines. LPS, however, does not cause extensive epithelial and endothelial damage in mice. 
This damage can be seen in human ARDS patients. The dose response in mice also differs since 
they lack PIM. Mice require higher dose of LPS (mg/kg range) to develop lung injury features, 
whereas humans can develop severe inflammation with a much smaller dose (μg/kg range). It is 
also important to note that mice and humans have evolved under widely different environmental 
pressures over the past millions of years. This has resulted in some changes in their immune 
systems to face specific pathogenic challenges endemic to their environments. One such 
difference is lack of IL-8 in mice, however, mice have KC which is a functional homologue of 
IL-8. Our protein of interest, CD34, also shares high sequence similarity across different species 
and the C-terminal of CD34 is a highly conserved region across species, including humans and 
mice. In conclusion, a mice model of ALI can be seen as an acceptable animal model in 
understanding the role of CD34 in LPS-induced acute lung inflammation.   
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APPENDIX A: BAL MONOCYTE AND LYMPHOCYTE COUNTS 
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Fig.A.1.A, B: BAL Monocyte and Lymphocyte Counts:  Total Bronchoalveolar Lavage Fluid 
(BAL) monocyte counts(A) and lymphocyte counts(B) at various time points (0 h, 3, 9, 15, 24 h) 
in WT (WT, N=5-7; at 15h, N=3) and CD34 KO (N=5-7; at 15h, N=3) mice. The data is lognormal 
as per the Shapiro-Wilk test. Hence, logarithmic transformation was applied to the original data, 
followed by two-way ANOVA with Dunnett’s multiple comparisons test.  Results are expressed 
as mean ± SD. WT vs CD34 p>0.05, ns 
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The cell surface protein CD34 has been observed to be expressed in various human tissues and 
cells including hematopoietic stem cells (2), vascular endothelial cells (3), mucosal dendritic cells 
(4), mast cells (5), eosinophils (6,7), microglia (8), fibrocytes (9), muscle satellite cells (10) and 
inactivated platelets (11). In canine models, CD34 expression has been observed in hematopoietic 
stem cells in bone marrow (12), peripheral blood and the hair follicle.  
The cytoplasmic region of CD34, encoded by exons 7 and 8, contains the highest degree of 
sequence similarity between human, murine, and canine CD34.There is greater than 90% amino 
acid identity, and approximately 92% nucleotide identity within this region. This region contains 
several known or potential protein kinase phosphorylation sites (13). In case of complete CD34 
protein, there is 70% amino acid identity between human and canine CD34. 
There is a lack of literature and studies related to the expression of CD34 in various organs and 
cells of canine and porcine models. Therefore, it would be appropriate to initiate the project with 
Immunohistochemistry experiments to observe CD34 expression in blood (various cells), liver and 
lungs in canine and porcine models. CD34 monoclonal antibodies for relevant species are available 










MATERIALS AND METHODS 
 
Western Blot: Western blots were performed on dog lungs. Protein extracts were separated by SDS-
PAGE and transferred onto PVDF membranes. They were probed with antibodies against CD34 
(Rabbit mAb, ab81289, 1: 10,000, Abcam Inc., Cambridge, MA, USA) and β-actin (Mouse mAb, 
ab8224, 1:1000, Abcam Inc., Cambridge, MA, USA). Proteins of interest were detected with 
fluorescein-conjugated bovine anti-mouse IgG-FITC antibody (sc-2366, 1: 1000, Santa Cruz 
Biotechnology, Inc., Dallas, Texas, USA) and Cy5-conjugated goat anti-rabbit IgG antibody 
(ab97077, 1: 1000, Abcam Inc., Cambridge, MA, USA). 
Immunohistochemistry: Tissue sections were deparaffinized with xylene and rehydrated in an 
ethanol series. Endogenous peroxidase activity was inactivated with 0.5% H2O2 in methanol in 
dark for 20 mins at room temperature. After washing, antigen retrieval was performed by 
incubating sections with warmed pepsin (2 mg/ml in 0.01N HCl) at 37°C for 40 min. After 
washing, they were blocked with 1% bovine serum albumin (BSA) in 1% PBS for 30 min at room 
temperature. The sections were then incubated overnight at 4°C with either primary antibodies 
against CD34 (rabbit monoclonal EP373Y, ab81289, 1:500, Abcam Inc., Cambridge, MA, USA), 
Von Willebrand Factor (A0082, 1:300, Dako Denmark A/S, Glostrup, Denmark) or 1% BSA 
(negative control). After washing, they were incubated with secondary antibody (HRP-conjugated 
goat anti-rabbit IgG antibody, P0448, 1:500, Dako Denmark A/S, Glostrup, Denmark) for 30 min 
at room temperature. The sections were developed with VECTOR VIP Peroxidase (HRP) substrate 
kit (SK-4600, VECTOR Laboratories Inc., Burlingame, CA, USA) at room temperature for 5 min 
and counterstained with methyl green. Sections were then dehydrated in an ethanol series and cover 
slips were mounted with mounting medium.  
Immunofluorescence staining (IF): IF was performed to look at the CD34 expression in WT mice 
lungs at 0h time-point. Tissue sections were deparaffinized with xylene and rehydrated in an 
ethanol series. Endogenous peroxidase activity was inactivated with 0.5% H2O2 in methanol in 
dark for 20 mins at room temperature. After washing, antigen retrieval was performed in two steps. 
Firstly, heat induced epitope retrieval (HIER) was performed by incubating sections in sodium 
citrate buffer (10mM, pH 6.0) at 90°C-95°C for 20 minutes. Then, the sections were allowed to 
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cool in distilled water, following which the sections were incubated with warmed pepsin (2 mg/ml 
in 0.01N HCl) at 37°C for 20 min. After washing, they were blocked with 1% bovine serum 
albumin in 1% PBS for 30 min at room temperature. The sections were then incubated overnight 
at 4°C with 100 µL primary antibodies per section against CD34 (rabbit anti-mouse, EP373Y, 
ab81289, 1:500, Abcam Inc., Cambridge, MA, USA). Next day, the slides were left at room 
temperature for 30 min followed by washing with PBS 1X thrice. After washing, they were 
incubated with 100 µL secondary antibody per section (AF488, green) for 30 min at room 
temperature (in dark). After washing, sections were counterstained with DAPI. Sections were then 
allowed to dry, and cover slips were mounted with Prolong gold mounting medium. Media was 
then allowed to cure for 24 hours before sealing the cover slip with nail varnish. Stained slides 
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Fig.B.1: Immunohistochemical staining in dog lung sections: Immunohistochemistry was 
performed on normal dog lungs (N=2). Black arrows pointing at positive staining for CD34 
antibody. B.V: Blood vessel; E: Epithelia; i: Interstitium; L: Leukocyte; A.S: Alveolar space. 













Fig.B.2: Western Blot analysis in dog lung sections: Western blot was performed on normal dog 






Fig.B.3: Immunohistochemical staining in pig lung sections: Immunohistochemistry was 
performed on normal pig lungs (N=2) and Swine influenza pig lungs (N=2). Black arrows 
pointing at positive staining for CD34 antibody. B.V: Blood vessel; A.S: Alveolar space. Positive 













Fig.B.4: CD34 immunofluorescence staining in WT mouse lung section: Immunofluorescence 
staining on WT mouse lungs was performed for various time points: 0 (no LPS), 9 and 24h in WT 
(WT, N=2) mice exposed to 50 µg LPS. Green: CD34; Blue: DAPI, staining for cell nucleus. B: 















APPENDIX C: CYTOKINES AND CHEMOKINES 
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Error bar: Mean with SD
p = 0.0019
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Fig.C.1.A, B, C: IL-13, IL-9 and IL-3 content in BAL fluid: IL-13, IL-9 and IL-3 in the BAL 
samples at various time points (0 h, 3, 9, 15, 24 h) in WT (WT, N=5-7) and CD34 KO (N=5-7) 
mice. Data sets were analyzed using two-way ANOVA with Dunnett’s multiple comparisons test 
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Fig. C.2.A, B: IL-4 and IL-2 content in BAL fluid: IL-4 and IL-2 in the BAL samples at 
various time points (0 h, 3, 9, 15, 24 h) in WT (WT, N=5-7) and CD34 KO (N=5-7) mice. 
Data sets were analyzed using two-way ANOVA with Dunnett’s multiple comparisons 
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Fig. C.3: IL-5 content in BAL fluid: IL-5 in the BAL samples at various time points (0 h, 3, 9, 15, 
24 h) in WT (WT, N=5-7) and CD34 KO (N=5-7) mice. Data sets were analyzed using two-way 
ANOVA with Dunnett’s multiple comparisons test (p-values shown in the graph above). All results 
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Fig.C.4: IL-17 content in BAL fluid: IL-17 in the BAL samples at various time points (0 h, 3, 9, 
15, 24 h) in WT (WT, N=5-7) and CD34 KO (N=5-7) mice. Data sets were analyzed using two-
way ANOVA with Dunnett’s multiple comparisons test (p-values shown in the graph above). All 
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Fig.C.5: IL-1a content in BAL fluid: IL-1a in the BAL samples at various time points (0 h, 3, 9, 
15, 24 h) in WT (WT, N=5-7) and CD34 KO (N=5-7) mice. Data sets were analyzed using two-
way ANOVA with Dunnett’s multiple comparisons test (p-values shown in the graph above). All 
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Fig.C.6: Eotaxin content in BAL fluid: RANTES in the BAL samples at various time points (0 h, 
3, 9, 15, 24 h) in WT (WT, N=5-7) and CD34 KO (N=5-7) mice. Data sets were analyzed using 
two-way ANOVA with Dunnett’s multiple comparisons test (p-values shown in the graph above). 
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